| EOS-AX5963 | B-Raf IN 1 | 950736-05-7 | C29H24F3N5O | 515.53 | CN(CC1=CC=C(C(C=NN23)=C3N=CC=C2C4=CC(/N=C(O)/C5=CC(C(F)(F)F)=CC=C5)=CC=C4)C=C1)C |
| EOS-AX5964 | KX1-004 | 518058-84-9 | C16H13FN2O2 | 284.29 | FC1=CC(C=C(C(NCC2=CC=CC(O)=C2)=O)N3)=C3C=C1 |
| EOS-AX5965 | RU-SKI 43 | 1043797-53-0 | C22H30N2O2S | 386.55 | CCC(CNCC(N1CCC2=C(C1COC3=CC=CC(C)=C3)C=CS2)=O)C |
| EOS-AX5966 | 5S rRNA modificator | 1415238-77-5 | C9H8N2O2 | 176.17 | CC1=C(C(N2C=CN=C2)=O)C=CO1 |
| EOS-AX5967 | LY-411575 isomer 1 | 209984-58-7 | C26H23F2N3O4 | 479.48 | C[C@@](/N=C(O)/[C@@](O)([H])C1=CC(F)=CC(F)=C1)([H])/C(O)=N/[C@@](C2=O)([H])C3=CC=CC=C3C4=CC=CC=C4N2C |
| EOS-AX5968 | LY-411575 isomer 2 | C26H23F2N3O4 | 479.48 | C[C@](/N=C(O)/[C@](O)([H])C1=CC(F)=CC(F)=C1)([H])/C(O)=N/[C@@](C2=O)([H])C3=CC=CC=C3C4=CC=CC=C4N2C | |
| EOS-AX5969 | LY-411575 isomer 3 | C26H23F2N3O4 | 479.48 | C[C@](/N=C(O)/[C@@](O)([H])C1=CC(F)=CC(F)=C1)([H])/C(O)=N/[C@@](C2=O)([H])C3=CC=CC=C3C4=CC=CC=C4N2C | |
| EOS-AX5970 | Mutated EGFR-IN-1 | 1421372-66-8 | C25H31N7O | 445.56 | CN(CCN(C1=CC(OC)=C(NC2=NC=CC(C(C3=CC=CC=C34)=CN4C)=N2)C=C1N)C)C |
| EOS-AX5971 | THZ1 Hydrochloride | C31H29Cl2N7O2 | 602.51 | ClC(C=N1)=C(C2=CNC3=C2C=CC=C3)N=C1NC4=CC(NC(C5=CC=C(NC(/C=C/CN(C)C)=O)C=C5)=O)=CC=C4.Cl | |
| EOS-AX5972 | Oxybenzone | 131-57-7 | C14H12O3 | 228.24 | |
| EOS-AX5973 | Aurothioglucose | 12192-57-3 | C6H11AuO5S | 392.18 | |
| EOS-AX5974 | (S)-10-Hydroxycamptothecin | 19685-09-7 | C20H16N2O5 | 364.35 | CC[C@]1(O)C(C=C2C3=C(CN2C4=O)C=C5C=C(O)C=CC5=N3)=C4COC1=O |
| EOS-AX5975 | Oxiracetam | 62613-82-5 | C6H10N2O3 | 158.16 | N=C(O)CN1CC(O)CC1=O |
| EOS-AX5976 | SC75741 | 913822-46-5 | C29H23N7O2S2 | 565.67 | O=C(C1=CC2=C(N=C(/N=C(O)/C3=CSC(C4CCN(C5=NC=NC6=C5SC=C6)CC4)=N3)N2)C=C1)C7=CC=CC=C7 |
| EOS-AX5977 | (-)-p-Bromotetramisole Oxalate | 62284-79-1 | C13H13BrN2O4S | 373.22 | BrC(C=C1)=CC=C1[C@H]2N=C3SCCN3C2.OC(C(O)=O)=O |
| EOS-AX5978 | L-Mimosine | 500-44-7 | C8H10N2O4 | 198.18 | N[C@@](C(O)=O)([H])CN(C=C1O)C=CC1=O |
| EOS-AX5979 | FPH2 (BRD-9424) | 957485-64-2 | C14H16ClN5O2S | 353.83 | CCN1C=C(N/C(S)=N/C2=C(OC)C=CC(Cl)=C2)C(C(N)=O)=N1 |
| EOS-AX5980 | LDC000067 | 1073485-20-7 | C18H18N4O3S | 370.43 | COC1=CC=CC=C1C2=CC(NC3=CC=CC(CS(N)(=O)=O)=C3)=NC=N2 |
| EOS-AX5981 | PI-1840 | 1401223-22-0 | C22H26N4O3 | 394.47 | CCCC1=CC=C(OCC(N(C(C)C)CC2=NC(C3=CN=CC=C3)=NO2)=O)C=C1 |
| EOS-AX5982 | YH239-EE | 1364488-67-4 | C25H27Cl2N3O4 | 504.41 | CCOC(C1=C(C(N(C=O)CC2=CC=C(Cl)C=C2)/C(O)=N/C(C)(C)C)C3=C(N1)C=C(Cl)C=C3)=O |
| EOS-AX5983 | INH6 | 1001753-24-7 | C19H18N2OS | 322.42 | O=C(C1=CC=CC=C1)NC2=NC(C3=C(C)C=C(C)C=C3C)=CS2 |
| EOS-AX5984 | BAPTA-AM | 126150-97-8 | C34H40N2O18 | 764.68 | O=C(CN(CC(OCOC(C)=O)=O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(OCOC(C)=O)=O)CC(OCOC(C)=O)=O)OCOC(C)=O |
| EOS-AX5985 | Raltegravir potassium salt | 871038-72-1 | C20H20FKN6O5 | 482.51 | CC(O1)=NN=C1C(NC(C)(C2=NC(/C(O)=N/CC3=CC=C(F)C=C3)=C([O-])C(N2C)=O)C)=O.[K+] |
| EOS-AX5986 | GNE-9605 | 1536200-31-3 | C17H20ClF4N7O | 449.83 | CNC1=NC(NC2=C(Cl)N([C@@H]3[C@@H](F)CN(C4COC4)CC3)N=C2)=NC=C1C(F)(F)F |
| EOS-AX5987 | HG6-64-1 | 1315329-43-1 | C32H34F3N5O2 | 577.64 | CCN1CCN(CC2=C(C(F)(F)F)C=C(NC(C(C=C3/C([H])=C([H])/C4=CNC5=NC=CC5=C4OC)=CC=C3C)=O)C=C2)CC1 |
| EOS-AX5988 | GKT137831 | 1218942-37-0 | C21H19ClN4O2 | 394.85 | CN(C1=CC=CC(C2=C(C3=O)C(NN3C4=CC=CC=C4Cl)=CC(N2C)=O)=C1)C |
| EOS-AX5989 | TCS-PIM-1-4a | 327033-36-3 | C11H6F3NO2S | 273.23 | O=C(NC(S/1)=O)C1=C\C2=CC=CC(C(F)(F)F)=C2 |
| EOS-AX5990 | kb-NB77-78 | 1350622-33-1 | C18H25NO3Si | 331.48 | CC(C)([Si](C)(OC1=CC(C(CCCN2)=C2C3=O)=C(O3)C=C1)C)C |
| EOS-AX5991 | PNU-159682 | 202350-68-3 | C32H35NO13 | 641.62 | C[C@@]1([H])[C@]2([H])[C@](N3CCO[C@@](OC)([H])[C@@]3([H])O2)([H])C[C@@](O[C@@]4([H])C[C@@](C(CO)=O)(O)CC(C4=C5O)=C(O)C6=C5C(C7=C(C6=O)C=CC=C7OC)=O)([H])O1 |
| EOS-AX5992 | Amicarbazone | 129909-90-6 | C10H19N5O2 | 241.29 | CC(C(N1N)=NN(C1=O)/C(O)=N/C(C)(C)C)C |
| EOS-AX5993 | Ipfencarbazone | 212201-70-2 | C18H14Cl2F2N4O2 | 427.23 | CC(N(C(N(C1=O)C=NN1C2=C(Cl)C=C(Cl)C=C2)=O)C3=C(F)C=C(F)C=C3)C |
| EOS-AX5994 | Novaluron | 116714-46-6 | C17H9ClF8N2O4 | 492.7 | ClC1=C(OC(F)(F)C(OC(F)(F)F)F)C=CC(/N=C(O)/N=C(O)/C2=C(F)C=CC=C2F)=C1 |
| EOS-AX5995 | Flumorph | 211867-47-9 | C21H22FNO4 | 371.4 | COC1=C(OC)C=C(/C(C2=CC=C(F)C=C2)=C([H])/C(N3CCOCC3)=O)C=C1 |
| EOS-AX5996 | Meptyldinocap | 131-72-6 | C18H24N2O6 | 364.39 | CCCCCCC(C1=C(OC(/C([H])=C([H])/C)=O)C(N(=O)=O)=CC(N(=O)=O)=C1)C |
| EOS-AX5997 | Athidathion | 19691-80-6 | C8H15N2O4PS3 | 330.38 | CCOP(OCC)(SCN(N=C(S1)OC)C1=O)=S |
| EOS-AX5998 | Benoxafos | 16759-59-4 | C12H14Cl2NO3PS2 | 386.25 | CCOP(OCC)(SCC1=NC2=CC(Cl)=CC(Cl)=C2O1)=S |
| EOS-AX5999 | Bethoxazin | 163269-30-5 | C11H9NO2S2 | 251.32 | O=S1CCON=C1C2=CC3=CC=CC=C3S2 |
| EOS-AX6000 | Bromethalin | 63333-35-7 | C14H7Br3F3N3O4 | 577.93 | CN(C1=C(Br)C=C(Br)C=C1Br)C2=C(C(F)(F)F)C=C(N(=O)=O)C=C2N(=O)=O |
| EOS-AX6001 | Cloxyfonac | 6386-63-6 | C9H9ClO4 | 216.62 | ClC1=CC=C(OCC(O)=O)C(CO)=C1 |
| EOS-AX6002 | Cyhalofop | 122008-78-0 | C16H12FNO4 | 301.27 | C[C@](OC1=CC=C(OC2=C(F)C=C(C#N)C=C2)C=C1)([H])C(O)=O |
| EOS-AX6003 | Aldicarb | 116-06-3 | C7H14N2O2S | 190.26 | CC(/C([H])=N/O/C(O)=N/C)(SC)C |
| EOS-AX6004 | Aldicarb sulfone | 1646-88-4 | C7H14N2O4S | 222.26 | CC(/C([H])=N/O/C(O)=N/C)(S(C)(=O)=O)C |
| EOS-AX6005 | NSC-41589 | 6310-41-4 | C9H11NOS | 181.25 | C/C(O)=N/C1=CC=CC=C1SC |
| EOS-AX6006 | Tildipirosin | 328898-40-4 | C41H71N3O8 | 734.02 | CC[C@](O1)([H])[C@](CN2CCCCC2)([H])/C([H])=C(/C([H])=C([H])/C([C@](C[C@]([C@@](O[C@@]3([H])[C@@](O)([H])[C@](N(C)C)([H])[C@@](O)([H])[C@@](O3)([H])C)([H])[C@@]([C@@](O)([H])CC1=O)([H])C)([H])CCN4CCCCC4)([H])C)=O)C |
| EOS-AX6007 | Epibrassinolide | 78821-43-9 | C28H48O6 | 480.68 | CC([C@@]([C@](O)([H])[C@@](O)([H])[C@@]([C@@]1([H])CC[C@@]2([H])[C@]([C@]3([H])CC[C@]12C)([H])COC([C@@]4([H])C[C@@](O)([H])[C@@](O)([H])C[C@]34C)=O)([H])C)([H])C)C |
| EOS-AX6008 | Diphenidol HCl | 3254-89-5 | C21H28ClNO | 345.91 | OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCCN3CCCCC3.Cl |
| EOS-AX6009 | Promethazine HCl | 58-33-3 | C17H21ClN2S | 320.88 | CC(N(C)C)CN1C2=CC=CC=C2SC3=CC=CC=C31.Cl |
| EOS-AX6010 | Dicoumarol | 66-76-2 | C19H12O6 | 336.29 | OC(C1=CC=CC=C1OC2=O)=C2CC3=C(O)C4=CC=CC=C4OC3=O |
| EOS-AX6011 | Zotarolimus(ABT-578) | 221877-54-9 | C52H79N5O12 | 966.21 | |
| EOS-AX6012 | SF1670 | 345630-40-2 | C19H17NO3 | 307.34 | CC(C)(C(NC(C=C1C2=O)=CC=C1C3=C(C2=O)C=CC=C3)=O)C |
| EOS-AX6013 | SH-4-54 | 1456632-40-8 | C29H27F5N2O5S | 610.59 | FC(C(S(=O)(N(C)CC(N(C1=CC=C(C(O)=O)C=C1)CC2=CC=C(C=C2)C3CCCCC3)=O)=O)=C(C(F)=C4F)F)=C4F |
| EOS-AX6014 | Phosphoramidon Disodium Salt | 164204-38-0 | C23H34N3Na2O10P | 587.47 | CC(C[C@@](NP(O)(O[C@@]1([H])[C@@](O)([H])[C@@](O)([H])[C@](O)([H])[C@](O1)([H])C)=O)([H])/C([O-])=N/[C@@](C([O-])=O)([H])CC2=CNC3=CC=CC=C23)C.[Na+].[Na+] |
| EOS-AX6015 | PD 151746 | 179461-52-0 | C11H8FNO2S | 237.25 | FC1=CC(C(/C([H])=C(S)/C(O)=O)=CN2)=C2C=C1 |
| EOS-AX6016 | SB-3CT | 292605-14-2 | C15H14O3S2 | 306.4 | O=S(CC1CS1)(C2=CC=C(OC3=CC=CC=C3)C=C2)=O |
| EOS-AX6017 | IM-12 | 1129669-05-1 | C22H20FN3O2 | 377.41 | FC1=CC=C(C=C1)CCNC2=C(C(N(C)C2=O)=O)C3=C(C)NC4=CC=CC=C34 |
| EOS-AX6018 | Santacruzamate A (CAY10683) | 1477949-42-0 | C15H22N2O3 | 278.35 | CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1 |
| EOS-AX6019 | Labetalol HCl | 32780-64-6 | C19H25ClN2O3 | 364.87 | CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl |
| EOS-AX6020 | Meclofenamate Sodium | 6385-02-0 | C14H11Cl2NO2.Na | 318.13 | CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+] |
| EOS-AX6021 | HSP990 (NVP-HSP990) | 934343-74-5 | C20H18FN5O2 | 379.39 | CC1=NC(=NC2=C1C(=O)NC(C2)C3=C(C=C(C=C3)F)C4=NC(=CC=C4)OC)N |
| EOS-AX6022 | Procainamide HCl | 614-39-1 | C13H22ClN3O | 271.79 | CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl |
| EOS-AX6023 | CB-839 | 1439399-58-2 | C26H24F3N7O3S | 571.57 | FC(F)(F)OC1=CC(CC(NC2=NN=C(CCCCC3=NN=C(NC(CC4=NC=CC=C4)=O)S3)C=C2)=O)=CC=C1 |
| EOS-AX6024 | Defactinib | 1073154-85-4 | C20H21F3N8O3S | 510.49 | CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F |
| EOS-AX6025 | PEAQX | 459836-30-7 | C17H17BrN3O5P | 454.21 | CC(C1=CC=C(C=C1)Br)NC(C2=C3C(=CC=C2)NC(=O)C(=O)N3)P(=O)(O)O |
| EOS-AX6026 | Mps1-IN-3 | 1609584-72-6 | C26H31N7O4S | 537.63 | O=S(C1=C(NC2=NC(NC3=CC=C(N4CCC(O)CC4)C=C3OC)=NC5=C2N=CN5)C=CC=C1)(C(C)C)=O |
| EOS-AX6027 | Brivaracetam | 357336-20-0 | C11H20N2O2 | 212.29 | |
| EOS-AX6028 | Firocoxib | 189954-96-9 | C17H20O5S | 336.4 | CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C |
| EOS-AX6029 | RG7090 | 802906-73-6 | C18H13ClFN3 | 325.77 | CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl |
| EOS-AX6030 | K-115 | 887375-67-9 | C15H23ClFN3O4S | 395.88 | CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F.O.O.Cl |
| EOS-AX6031 | K-115 free base | 223645-67-8 | C15H18FN3O2S | 323.39 | CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F |
| EOS-AX6032 | Afuresertib | 1047644-62-1 | C18H17Cl2FN4OS | 427.32 | CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl |
| EOS-AX6033 | Pifithrin-β | 60477-34-1 | C16H16N2S | 268.38 | CC1=CC=C(C=C1)C2=CN3C4=C(CCCC4)SC3=N2 |
| EOS-AX6034 | ESI-09 | 263707-16-0 | C16H15ClN4O2 | 330.77 | CC(C)(C)C1=CC(=NO1)C(=O)C(=NNC2=CC(=CC=C2)Cl)C#N |
| EOS-AX6035 | LCZ696 | 936623-90-4 | C48H54N6Na3O8.2.5H2O | 956.99 | CCCCC(N([C@@](C([O-])=O)([H])C(C)C)CC1=CC=C(C2=CC=CC=C2C3=N[N-]N=N3)C=C1)=O.CCOC([C@](C[C@@](/N=C([O-])/CCC([O-])=O)([H])CC4=CC=C(C5=CC=CC=C5)C=C4)([H])C)=O.[3Na+].[2.5H2O] |
| EOS-AX6036 | 10-Deacetyl-7-xylosyl paclitaxel | 90332-63-1 | C50H57NO17 | 943.98 | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)OC8C(C(C(CO8)O)O)O)C)O |
| EOS-AX6037 | PTP1B-IN-1 | 612530-44-6 | C8H8N2O3S | 212.23 | C1C(=O)NS(=O)(=O)N1C2=CC=CC=C2 |
| EOS-AX6038 | WAY-262611 | 1123231-07-1 | C20H22N4 | 318.42 | C1CN(CCC1CN)C2=NC=CC(=N2)C3=CC4=CC=CC=C4C=C3 |
| EOS-AX6039 | NVP-QAV680 | 872365-16-7 | C18H18N2O4S | 358.41 | CC1=C(C2=C(N1CC3=CC=C(C=C3)S(=O)(=O)C)N=CC=C2)CC(=O)O |
| EOS-AX6040 | BMS-983970 | 1584713-87-0 | C26H26F4N4O3 | 518.5 | FC1=C(NC([C@@H]([N@@H]2C([C@H](CCC(F)(F)F)[C@H](CC3CC3)C([NH2]2)=O)=O)N=C4C5=CC=CC=C5)=O)C4=CC=C1 |
| EOS-AX6041 | BET-BAY 002 | 1588521-78-1 | C22H18ClN5O | 403.86 | CC1=NN=C2[C@H](CC3=NN=C(C)O3)C=C(C4=CC=C(Cl)C=C4)C5=CC=CC=C5N21 |
| EOS-AX6042 | DGAT1-IN-1 | 1449779-49-0 | C30H28F3N3O4 | 551.56 | OC(C[C@H]1CC[C@H](C2=CC=C(C3=CN4C(C=C3)=NC(C(NCC5=CC=C(OC(F)(F)F)C=C5)=O)=C4)C=C2)CC1)=O |
| EOS-AX6043 | mAChR-IN-1 | 119391-56-9 | C23H25IN2O2 | 488.36 | C1CN(CCC1C2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=C(C=C4)I |
| EOS-AX6044 | FICZ | 172922-91-7 | C19H12N2O | 284.31 | O=CC1=C2C(NC3=CC=CC=C23)=CC4=C1NC5=CC=CC=C45 |
| EOS-AX6045 | IKKε-IN-1 | 1292310-49-6 | C26H27N5O3 | 457.52 | N#CC1=CC(C2=NC(NC3=CC=C(C=C3)N4CCOCC4)=NC=C2)=CC=C1OC5CCOCC5 |
| EOS-AX6046 | Isavuconazole | 241479-67-4 | C22H17F2N5OS | 437.47 | CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O |
| EOS-AX6047 | JNJ-31020028 | 1094873-14-9 | C34H36FN5O2 | 565.68 | CCN(CC)C(=O)C(C1=CC=CC=C1)N2CCN(CC2)C3=C(C=C(C=C3)NC(=O)C4=CC=CC=C4C5=CN=CC=C5)F |
| EOS-AX6048 | TBPB | 634616-95-8 | C25H32N4O | 404.55 | CC1=CC=CC=C1CN2CCC(CC2)N3CCC(CC3)N4C5=CC=CC=C5NC4=O |
| EOS-AX6049 | Tecovirimat | 869572-92-9 | C19H15F3N2O3 | 376.33 | C1C2C1C3C=CC2C4C3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F |
| EOS-AX6050 | RGB-286638 | 784210-87-3 | C29H37Cl2N7O4 | 618.55 | COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=NNC4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6.Cl.Cl |
| EOS-AX6051 | RGB-286638 free base | 784210-88-4 | C29H35N7O4 | 545.63 | COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=NNC4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6 |
| EOS-AX6052 | Emapunil | 226954-04-7 | C23H23N5O2 | 401.46 | CCN(CC1=CC=CC=C1)C(=O)CN2C3=NC(=NC=C3N(C2=O)C)C4=CC=CC=C4 |
| EOS-AX6053 | Auristatin F | 163768-50-1 | C40H67N5O8 | 745.99 | CC[C@H](C)[C@H](N(C([C@@H](NC([C@@H](N(C)C)C(C)C)=O)C(C)C)=O)C)[C@H](OC)CC(N1CCC[C@@]1([H])[C@H](OC)[C@@H](C)C(N[C@H](C(O)=O)CC2=CC=CC=C2)=O)=O |
| EOS-AX6054 | Efinaconazole | 164650-44-6 | C18H22F2N4O | 348.39 | CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3 |
| EOS-AX6055 | CBB1003 | 1379573-88-2 | C25H31N9O4 | 521.57 | NC(N1CCN(CC2=CC(C(N3CCN(C(C4=CC=C(C(N)=N)C=C4)=O)CC3)=O)=CC([N+]([O-])=O)=C2)CC1)=N |
| EOS-AX6056 | CPI-360 | 1802175-06-9 | C25H31N3O4 | 437.53 | CC(N1)=CC(OC)=C(CNC(C2=C(C)N([C@H](C)C3CCOCC3)C4=CC=CC=C24)=O)C1=O |
| EOS-AX6057 | BRD4770 | 1374601-40-7 | C25H23N3O3 | 413.47 | COC(=O)C1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC=CC=C3)CCCC4=CC=CC=C4 |
| EOS-AX6058 | Z-Ile-Glu-Pro-Phe-Ome | 255257-97-4 | C34H44N4O9 | 652.73 | COC([C@@H](NC([C@H]1N(CCC1)C([C@H](CCC(O)=O)NC([C@H]([C@@H](C)CC)NC(OCC2=CC=CC=C2)=O)=O)=O)=O)CC3=CC=CC=C3)=O |
| EOS-AX6059 | ZLN024 | 723249-01-2 | C13H13BrN2OS | 325.22 | CC1=CC=C(OCCSC2=NC=CC=N2)C(Br)=C1 |
| EOS-AX6060 | ZLN024 hydrochloride | C13H14BrClN2OS | 361.69 | CC1=CC=C(OCCSC2=NC=CC=N2)C(Br)=C1.[H]Cl | |
| EOS-AX6061 | USP7-IN-1 | 1381291-36-6 | C23H24ClN3O3 | 425.91 | |
| EOS-AX6062 | LDN-214117 | 1627503-67-6 | C25H29N3O3 | 419.52 | CC(C(C1=CC(OC)=C(OC)C(OC)=C1)=C2)=NC=C2C(C=C3)=CC=C3N4CCNCC4 |
| EOS-AX6063 | Decloxizine | 3733-63-9 | C21H28N2O2 | 340.46 | C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=CC=C3 |
| EOS-AX6064 | CaMKII-IN-1 | 1208123-85-6 | C29H30ClN5O2S | 548.1 | O=S(NC1=C2CN(CC3=CC=CC=C3)CCC2=NC(NCCC4=CC=CC=C4)=N1)(C5=CC=CC(Cl)=C5C)=O |
| EOS-AX6065 | BI 224436 | 1155419-89-8 | C27H26N2O4 | 442.51 | CC1=NC2=CC=CC=C2C(=C1C(C(=O)O)OC(C)(C)C)C3=C4C5=C(C=C3)OCCC5=CC=N4 |
| EOS-AX6066 | LB-100 | 1026680-07-8 | C13H20N2O4 | 268.31 | CC1=CC(=C(N1NC(=O)OC(C)(C)C)C)C(=O)OC |
| EOS-AX6067 | Chitinase-IN-1 | 1579991-61-9 | C18H16N4O2S | 352.41 | O=C(C1=CC=CC2=C1C3=CC=C2)N(CCNCC4=NN=C(C)S4)C3=O |
| EOS-AX6068 | Chitinase-IN-2 | 1579991-63-1 | C20H21N5O2S | 395.48 | O=C(C1=CC=CC2=C1C3=CC=C2N(C)C)N(CCNCC4=NN=C(C)S4)C3=O |
| EOS-AX6069 | Azimilide | 149908-53-2 | C23H28ClN5O3 | 457.95 | CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl |
| EOS-AX6070 | Azimilide Dihydrochloride | 149888-94-8 | C23H30Cl3N5O3 | 530.88 | CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl.Cl.Cl |
| EOS-AX6071 | (±)-BI-D | 1416258-16-6 | C25H27NO4 | 405.49 | CC1=NC2=C(C=CC=C2)C(C3=CC4=C(C=C3)OCCC4)=C1C(C(O)=O)OC(C)(C)C |
| EOS-AX6072 | K-Ras G12C-IN-1 | 1629265-17-3 | C22H23Cl2N3O3 | 448.34 | ClC1=CC=CC=C1C2=C(Cl)C=C(OC)C(NCC(N3CCN(C(C=C)=O)CC3)=O)=C2 |
| EOS-AX6073 | K-Ras G12C-IN-2 | 1629267-75-9 | C21H27ClN4O3 | 418.92 | ClC1=C(C2CC2)C=C(NCC(N3CCN(C4CN(C(C=C)=O)C4)CC3)=O)C(O)=C1 |
| EOS-AX6074 | K-Ras G12C-IN-3 | 1629268-19-4 | C21H19Cl3N2O3 | 453.75 | ClC1=C(C2=CC(Cl)=CC=C2Cl)C=C(C(N3CCN(C(C=C)=O)CC3)=O)C(OC)=C1 |
| EOS-AX6075 | Diclofensine hydrochloride | 34041-84-4 | C17H18Cl3NO | 358.69 | CN1CC(C2=C(C1)C=C(C=C2)OC)C3=CC(=C(C=C3)Cl)Cl.Cl |
| EOS-AX6076 | CAY10603 | 1045792-66-2 | C22H30N4O6 | 446.5 | CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO |
| EOS-AX6077 | YL-109 | 36341-25-0 | C14H11NO2S | 257.31 | COC1=CC(=C2NC3=CC=CC=C3S2)C=CC1=O |
| EOS-AX6078 | DZ2002 | 33231-14-0 | C10H13N5O3 | 251.24 | NC1=NC=NC2=C1N=CN2CCC(C(OC)=O)O |
| EOS-AX6079 | Ro 48-8071 | 161582-11-2 | C23H27BrFNO2 | 448.37 | CN(CCCCCCOC1=CC(=C(C=C1)C(=O)C2=CC=C(C=C2)Br)F)CC=C |
| EOS-AX6080 | Ro 48-8071 fumarate | 189197-69-1 | C27H31BrFNO6 | 564.44 | CN(CCCCCCOC1=CC(=C(C=C1)C(=O)C2=CC=C(C=C2)Br)F)CC=C.C(=CC(=O)O)C(=O)O |
| EOS-AX6081 | TZ9 | 1002789-86-7 | C17H14N6O4 | 366.33 | O=C(C1=CC=C([N+]([O-])=O)C=C1)OCC2=NC(N)=NC(NC3=CC=CC=C3)=N2 |
| EOS-AX6082 | CWHM-12 | 1564286-55-0 | C26H32BrN5O6 | 590.47 | CC(C)(C)C1=CC(=CC(=C1)C(CN(C(=O)CN)C(=O)C2=CC(=CC(=C2)O)NC3=NCC(CN3)O)C(=O)O)Br |
| EOS-AX6083 | Decloxizine dihydrochloride | 13073-96-6 | C21H30Cl2N2O2 | 413.38 | C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl |
| EOS-AX6084 | Tebipenem | 161715-21-5 | C16H21N3O4S2 | 383.49 | CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)C(C)O |
| EOS-AX6085 | Tylosin phosphate | 1405-53-4 | C46H80NO21P | 1014.1 | CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.OP(=O)(O)O |
| EOS-AX6086 | Fimasartan | 247257-48-3 | C27H31N7OS | 501.65 | CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C |
| EOS-AX6087 | 7ACC1 | 50995-74-9 | C14H15NO4 | 261.27 | CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C(=O)O |
| EOS-AX6088 | 7ACC2 | 1472624-85-3 | C18H15NO4 | 309.32 | C1C2C1C(C3=CC=CC=C3C2)OC(=O)C4=CC=C(C=C4)[N+](=O)[O-] |
| EOS-AX6089 | Cyclocytidine HCl | 10212-25-6 | C9H12ClN3O4 | 261.66 | C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N.Cl |
| EOS-AX6090 | Chloroprocaine HCl | 3858-89-7 | C13H20Cl2N2O2 | 307.22 | CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl.Cl |
| EOS-AX6091 | Ospemifene | 128607-22-7 | C24H23ClO2 | 378.89 | C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl |
| EOS-AX6092 | Mupirocin | 12650-69-0 | C26H44O9 | 500.62 | CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O |
| EOS-AX6093 | Nitenpyram | 150824-47-8 | C11H15ClN4O2 | 270.72 | CCN(CC1=CN=C(C=C1)Cl)C(=C[N+](=O)[O-])NC |
| EOS-AX6094 | Hydroxychloroquine Sulfate | 747-36-4 | C18H28ClN3O5S | 433.95 | CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O |
| EOS-AX6095 | PFI-2 | 1627676-59-8 | C23H25F4N3O3S | 499.52 | C1CCN(C1)C(=O)C(CC2=CC(=CC=C2)C(F)(F)F)NS(=O)(=O)C3=CC(=C4CNCCC4=C3)F |
| EOS-AX6096 | K-Ras(G12C) inhibitor 12 | 1469337-95-8 | C15H17ClIN3O3 | 449.67 | C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I |
| EOS-AX6097 | URMC-099 | 1229582-33-5 | C27H27N5 | 421.54 | CN1CCN(CC1)CC2=CC=C(C=C2)C3=CN=C4C(=C3)C(=CN4)C5=CC6=C(C=C5)NC=C6 |
| EOS-AX6098 | LY2119620 | 886047-22-9 | C19H24ClN5O3S | 437.94 | CC1=C2C(=C(SC2=NC(=C1Cl)OCC(=O)N3CCN(CC3)C)C(=O)NC4CC4)N |
| EOS-AX6099 | Blasticidin S HCl | 3513-03-9 | C17H27ClN8O5 | 458.9 | CN(CCC(CC(=O)NC1C=CC(OC1C(=O)O)N2C=CC(=NC2=O)N)N)C(=N)N.Cl |
| EOS-AX6100 | WS6 | 1421227-53-3 | C29H31F3N6O3 | 568.59 | CN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)CC3=CC=C(C=C3)OC4=NC=NC(=C4)NC(=O)C5CC5)C(F)(F)F |
| EOS-AX6101 | UMI-77 | 518303-20-3 | C18H14BrNO5S2 | 468.34 | C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br |
| EOS-AX6102 | PF-06463922 | 1454846-35-5 | C21H19FN6O2 | 406.41 | FC1=CC([C@H](OC2=C(N)N=CC(C3=C(C#N)N(C)N=C3CN4C)=C2)C)=C(C4=O)C=C1 |
| EOS-AX6103 | Abscisic Acid (Dormin) | 21293-29-8 | C15H20O4 | 264.32 | CC1=CC(=O)CC(C1(C=CC(=CC(=O)O)C)O)(C)C |
| EOS-AX6104 | RBC8 | 361185-42-4 | C25H20N4O3 | 424.45 | COC1=CC(C2C(C#N)=C(N)OC3=C2C(C4=CC=C5C(C=CC=C5)=C4)=NN3)=C(OC)C=C1 |
| EOS-AX6105 | Lomitapide | 182431-12-5 | C39H37F6N3O2 | 692.71 | C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F |
| EOS-AX6106 | DTP3 | C26H35N7O5 | 525.6 | CC(N[C@H](CC1=CC=C(O)C=C1)C(N[C@H](CCCNC(N)=N)C(N[C@H](CC2=CC=CC=C2)C(N)=O)=O)=O)=O | |
| EOS-AX6107 | Remodelin | 1622921-15-6 | C15H15BrN4S | 363.28 | C1CCC(=NNC2=NC(=CS2)C3=CC=C(C=C3)C#N)C1.Br |
| EOS-AX6108 | Obeticholic Acid | 459789-99-2 | C26H44O4 | 420.63 | CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O |
| EOS-AX6109 | Verdinexor (KPT-335) | 1392136-43-4 | C18H12F6N6O | 442.32 | C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F |
| EOS-AX6110 | HPOB | 1429651-50-2 | C17H18N2O4 | 314.34 | OCCN(C(CC1=CC=C(C(NO)=O)C=C1)=O)C2=CC=CC=C2 |
| EOS-AX6111 | ML324 | 1222800-79-4 | C21H23N3O2 | 349.43 | CN(CCCNC(C1=CC=C(C2=CC(O)=C3C(C=CC=N3)=C2)C=C1)=O)C |
| EOS-AX6112 | TAI-1 | 1334921-03-7 | C24H21N3O3S | 431.51 | COC1=CC=C(OC2=CC(C)=C(C3=CSC(NC(C4=CC=NC=C4)=C)=N3)C(C)=C2)C=C1 |
| EOS-AX6113 | LDC1267 | 1361030-48-9 | C30H26F2N4O5 | 560.55 | FC1=CC=C(N2C=C(OCC)C(C(NC3=CC=C(OC4=CC=NC5=CC(OC)=C(OC)C=C45)C(F)=C3)=O)=N2)C(C)=C1 |
| EOS-AX6114 | SP2509 | 1423715-09-6 | C19H20ClN3O5S | 437.9 | OC1=CC=C(Cl)C=C1/C(C)=N/NC(C2=CC=CC(S(=O)(N3CCOCC3)=O)=C2)=O |
| EOS-AX6115 | OF-1 | 919973-83-4 | C17H18BrN3O4S | 440.31 | CN1C2=C(C=C(OC)C(NS(=O)(C3=C(C)C=C(Br)C=C3)=O)=C2)N(C)C1=O |
| EOS-AX6116 | BMH-21 | 896705-16-1 | C21H20N4O2 | 360.41 | O=C1C2=C(C=C(C=CC=C3)C3=C2)N=C4C(C(NCCN(C)C)=O)=CC=CN41 |
| EOS-AX6117 | CCG-1423 | 285986-88-1 | C18H13ClF6N2O3 | 454.75 | FC(F)(F)C1=CC(C(F)(F)F)=CC(C(NOC(C)C(NC2=CC=C(Cl)C=C2)=O)=O)=C1 |
| EOS-AX6118 | Bikinin | 188011-69-0 | C9H9BrN2O3 | 273.08 | BrC1=CN=C(NC(CCC(O)=O)=O)C=C1 |
| EOS-AX6119 | BLZ945 | 953769-46-5 | C20H22N4O3S | 398.48 | O=C(NC)C1=NC=CC(OC2=CC3=C(N=C(N[C@@H]4CCCC[C@H]4O)S3)C=C2)=C1 |
| EOS-AX6120 | Indoximod (NLG-8189) | 110117-83-4 | C12H14N2O2 | 218.25 | OC([C@H](N)CC1=CN(C)C2=CC=CC=C21)=O |
| EOS-AX6121 | Pyridoclax | C29H22N4 | 426.51 | CC1=CC(C2=NC=C(C3=CC=CN=C3)C=C2/C=C/C4=CC=CC=C4)=CN=C1C5=CC=CN=C5 | |
| EOS-AX6122 | (+)-Apogossypol | 66389-74-0 | C28H30O6 | 462.53 | CC(C=C1C(C(C)C)=C(O)C(O)=CC1=C2O)=[C@]2[C@@]3=C(C)C=C4C(C=C(O)C(O)=C4C(C)C)=C3O |
| EOS-AX6123 | CX-4945 sodium salt | 1309357-15-0 | C19H11ClN3NaO2 | 371.75 | [O-]C(C1=CC=C2C(N=C(NC3CC(Cl)CCC3)C4=C2C=NC=C4)=C1)=O |
| EOS-AX6124 | ACTB-1003 | 939805-30-8 | C27H26F5N7O3 | 591.53 | COCC1=C(CN2CCOCC2)N3N=CN=C(N)C3=C1C4=CC=C(NC(NC5=CC(C(F)(F)F)=CC=C5F)=O)C(F)=C4 |
| EOS-AX6125 | GSK2190915 sodium salt | 1196070-26-4 | C38H42N3NaO4S | 659.81 | CCOC(C=C1)=NC=C1C2=CC=C(CN3C(CC(C([O-])=O)(C)C)=C(SC(C)(C)C)C4=CC(OCC5=CC=C(C)C=N5)=CC=C43)C=C2.[Na+] |
| EOS-AX6126 | PF-06447475 | 1527473-33-1 | C17H15N5O | 305.33 | N#CC1=CC=CC(C2=CNC3=NC=NC(N4CCOCC4)=C32)=C1 |
| EOS-AX6127 | Mps1-IN-1 | 1125593-20-5 | C28H33N5O4S | 535.66 | OC1CCN(C2=CC(OC)=C(NC3=NC4=C(C=CN4)C(NC5=C(S(=O)(C(C)C)=O)C=CC=C5)=C3)C=C2)CC1 |
| EOS-AX6128 | Z-Ile-Leu-aldehyde | 161710-10-7 | C20H30N2O4 | 362.46 | O=C(N[C@@H](C(N[C@@H](C=O)CC(C)C)=O)[C@@H](CC)C)OCC1=CC=CC=C1 |
| EOS-AX6129 | SAR407899 hydrochloride | 923262-96-8 | C14H17ClN2O2 | 280.75 | O=C(NC=C1)C(C1=C2)=CC=C2OC3CCNCC3.Cl |
| EOS-AX6130 | SAR407899 | 923359-38-0 | C14H16N2O2 | 244.29 | O=C(NC=C1)C(C1=C2)=CC=C2OC3CCNCC3 |
| EOS-AX6131 | EX-527 S-enantiomer | 848193-68-0 | C13H13ClN2O | 248.71 | ClC1=CC2=C(NC3=C2CCC[C@@H]3C(N)=O)C=C1 |
| EOS-AX6132 | EX-527 R-enantiomer | 848193-69-1 | C13H13ClN2O | 248.71 | ClC1=CC2=C(NC3=C2CCC[C@H]3C(N)=O)C=C1 |
| EOS-AX6133 | Corylifol A | 775351-88-7 | C25H26O4 | 390.47 | OC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1C/C=C(CC/C=C(C)/C)\C |
| EOS-AX6134 | ML224 | 1338824-21-7 | C31H31N3O5 | 525.59 | COC(C(COC1=C(C)C=C(NC(C)=O)C=C1C)=C2)=CC=C2C(NC3=C4C=CC=C3)N(C4=O)CC5=CC=CO5 |
| EOS-AX6135 | BAZ2-ICR | C20H19N7 | 357.41 | CN1N=CC(C2=C(C3=CC=C(C#N)C=C3)N(CCC4=CN(C)N=C4)C=N2)=C1 | |
| EOS-AX6136 | GSK 5959 | 901245-65-6 | C22H26N4O3 | 394.47 | O=C(C1=C(C=CC=C1)OC)NC2=C(C=C(N(C)C(N3C)=O)C3=C2)N4CCCCC4 |
| EOS-AX6137 | Ischemin sodium salt | C15H16N3O4SNa | 357.36 | NC(C=C(O)C(C)=C1)=C1/N=N/C2=C(C)C=C(C)C(S(=O)(O[Na])=O)=C2 | |
| EOS-AX6138 | OXF BD 02 | 1429129-68-9 | C18H17NO3 | 295.33 | OC1=CC(C2=C(C)ON=C2C)=CC(C(O)C3=CC=CC=C3)=C1 |
| EOS-AX6139 | Gap19 | 1507930-57-5 | C55H96N14O13 | 1161.45 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCCN)([H])CCC(O)=N)([H])[C@@](CC)([H])C)([H])CCC(O)=O)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCCCN)([H])CC1=CC=CC=C1)([H])CCCCN)([H])CCCCN)([H])C |
| EOS-AX6140 | EC 144 | 911397-80-3 | C21H24ClN5O2 | 413.9 | ClC1=C2C(N(CC3=C(C)C(OC)=C(C)C=N3)C=C2C#CCC(O)(C)C)=NC(N)=N1 |
| EOS-AX6141 | CCG 203971 | 1443437-74-8 | C23H21ClN2O3 | 408.88 | O=C(N1CCCC(C(NC2=CC=C(Cl)C=C2)=O)C1)C3=CC=CC(C4=CC=CO4)=C3 |
| EOS-AX6142 | IWP 4 | 686772-17-8 | C23H20N4O3S3 | 496.62 | O=C(N(C1=C(OC)C=CC=C1)C(SCC(NC2=NC(C=CC(C)=C3)=C3S2)=O)=N4)C5=C4CCS5 |
| EOS-AX6143 | TA 01 | 1784751-18-3 | C20H12F3N3 | 351.32 | FC1=CC=C(C2=C(C3=CC=NC=C3)NC(C4=C(F)C=CC=C4F)=N2)C=C1 |
| EOS-AX6144 | TA 02 | 1784751-19-4 | C20H13F2N3 | 333.33 | FC1=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=CC=C1 |
| EOS-AX6145 | C34 | 40592-88-9 | C17H27NO9 | 389.4 | CC(C)O[C@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O |
| EOS-AX6146 | ML 240 | 1346527-98-7 | C23H20N6O | 396.44 | NC1=NC2=C(C=CC=C2)N1C3=NC4=C(OC)C=CC=C4C(NCC5=CC=CC=C5)=N3 |
| EOS-AX6147 | CE3F4 | 143703-25-7 | C11H10Br2FNO | 351.01 | O=CN1C(C)CCC2=C(Br)C(F)=C(Br)C=C21 |
| EOS-AX6148 | CVT 10216 | 1005334-57-5 | C24H19NO7S | 465.48 | O=C(O)C1=CC=CC(COC2=CC=C3C(OC=C(C4=CC=C(NS(C)(=O)=O)C=C4)C3=O)=C2)=C1 |
| EOS-AX6149 | GSK 2837808A | 1445879-21-9 | C31H25F2N5O7S | 649.62 | O=S(C(C=N1)=C(NC2=CC(OC3=CC(F)=CC(F)=C3)=CC(C(O)=O)=C2)C(C1=C4)=CC=C4C5=CN=C(OC)N=C5OC)(NC6CC6)=O |
| EOS-AX6150 | TC-E 5002 | 1453071-47-0 | C15H27NO4 | 285.38 | O=C(N(O)CCC(O)=O)CCCCCCCCC1CC1 |
| EOS-AX6151 | TAK 21d | 1143578-94-2 | C19H17F2N7O | 397.38 | FC1=CC=C(C2=NC(N3CCN(C(NC4=CC=CN=N4)=O)CC3)=NC=C2)C=C1F |
| EOS-AX6152 | JJKK 048 | 1515855-97-6 | C23H22N4O5 | 434.44 | O=C(N1CCC(C(C2=CC=C(OCO3)C3=C2)C4=CC(OCO5)=C5C=C4)CC1)N6N=CN=C6 |
| EOS-AX6153 | ML 348 | 899713-86-1 | C18H17ClF3N3O3 | 415.79 | ClC1=C(NC(CN2CCN(C(C3=CC=CO3)=O)CC2)=O)C=C(C(F)(F)F)C=C1 |
| EOS-AX6154 | ML 349 | 890819-86-0 | C23H22N2O4S2 | 454.56 | COC1=CC=C(N2CCN(C(C3=CC4=C(C(C=CC=C5)=C5S(C4)(=O)=O)S3)=O)CC2)C=C1 |
| EOS-AX6155 | SCH 51344 | 171927-40-5 | C16H20N4O3 | 316.35 | CC1=NN=C(N2)C1=C(NCCOCCO)C3=C2C=CC(OC)=C3 |
| EOS-AX6156 | CKI 7 dihydrochloride | 1177141-67-1 | C11H12ClN3O2S.2HCl | 358.67 | O=S(C1=CC=C(Cl)C2=CC=NC=C21)(NCCN)=O |
| EOS-AX6157 | SB 706504 | 911110-38-8 | C24H19F3N8O | 492.46 | O=C1C=CC2=C(C3=C(C)C=C(F)C=C3)N=C(NCCNC(N[N+]#[C-])=N)N=C2N1C4=C(C=CC=C4F)F |
| EOS-AX6158 | ETP 45835 dihydrochloride | C13H16N4.2HCl | 301.21 | C1(C2=CC(C3=CC=NC=C3)=NN2)CCNCC1 | |
| EOS-AX6159 | 3PO | 13309-08-5 | C13H10N2O | 210.23 | O=C(C1=CC=NC=C1)/C=C/C2=CN=CC=C2 |
| EOS-AX6160 | T 5601640 | 924473-59-6 | C19H14F3N3O3 | 389.33 | O=C(C1=CC=CC(NC(C2=CC(C)=NO2)=O)=C1)NC3=CC(C(F)(F)F)=CC=C3 |
| EOS-AX6161 | UNC 3230 | 1031602-63-7 | C17H20N4O2S | 344.43 | NC(C1=C(NC(C2CCCCC2)=O)SC(NC3=CC=CC=C3)=N1)=O |
| EOS-AX6162 | Bryostatin 2 | 87745-28-6 | C45H66O16 | 863 | O[C@]1(O[C@H](C[C@@H](O)CC(O[C@H](C2)[C@H](O)C)=O)C[C@H](O)C1(C)C)C[C@H](C/3)O[C@@H](/C=C/C(C)(C)[C@@]4(O)[C@@H](OC(/C=C/C=C/CCC)=O)/C(C[C@@H]2O4)=C/C(OC)=O)CC3=C/C(OC)=O |
| EOS-AX6163 | Bryostatin 3 | 143370-84-7 | C46H64O17 | 888.99 | CC([C@@]1(O)[C@@H](OC(/C=C/C=C/CCC)=O)C([C@H]2[C@@H]3O1)=CC(O2)=O)(C)/C=C/[C@H](O[C@H](C[C@]4(O)O[C@H](C[C@@H](O)CC(O[C@@H]([C@H](O)C)C3)=O)C[C@H](OC(C)=O)C4(C)C)C/5)CC5=C/C(OC)=O |
| EOS-AX6164 | AZD 3988 | 892489-52-0 | C23H22F2N4O4 | 456.44 | O=C(C1=NN=C(NC2=CC(F)=C(F)C=C2)O1)NC(C=C3)=CC=C3[C@@H]4CC[C@@H](C[H])CC4.O=C=O |
| EOS-AX6165 | IWP 12 | 688353-45-9 | C18H18N4O2S3 | 418.56 | O=C1C2=C(CC(C)S2)N=C(SCC(NC3=NC(C=CC(C)=C4)=C4S3)=O)N1C |
| EOS-AX6166 | Garcinol | 78824-30-3 | C38H50O6 | 602.8 | O=C1[C@](C(O)=C2C(C3=CC(O)=C(O)C=C3)=O)(C[C@H](C/C=C(C)/C)C(C)=C)C[C@@H](C/C=C(C)/C)C(C)(C)[C@@]1(C/C=C(C)/C)C2=O |
| EOS-AX6167 | A 366 | 1527503-11-2 | C19H27N3O2 | 329.44 | NC1=NC2=CC(OCCCN3CCCC3)=C(OC)C=C2C14CCC4 |
| EOS-AX6168 | UNC 2400 | 1433200-49-7 | C35H47N7O2 | 597.79 | CC(C)N1CCN(C2=NC=C(C3=CC(N(C(C)C)N=C4)=C4C(C(N(C)CC5=C(CCC)C=C(C)N(C)C5=O)=O)=C3)C=C2)CC1 |
| EOS-AX6169 | WDR5 0103 | 890190-22-4 | C21H25N3O4 | 383.44 | COC(C1=CC(NC(C2=CC=CC(OC)=C2)=O)=C(N3CCN(C)CC3)C=C1)=O |
| EOS-AX6170 | Darunavir Ethanolate | 635728-49-3 | C29H43N3O8S | 593.73 | O[C@H](CN(CC(C)C)S(=O)(C(C=C1)=CC=C1N)=O)[C@H](CC2=CC=CC=C2)NC(O[C@@H]3[C@H]4[C@H](OCC4)OC3)=O.OCC |
| EOS-AX6171 | Chlorothiazide Sodium | 7085-44-1 | C7H5ClN3NaO4S2 | 317.71 | ClC1=C(C=C2S(=O)([N-]C=NC2=C1)=O)S(=O)(N)=O.[Na+] |
| EOS-AX6172 | Enalaprilat | 76420-72-9 | C18H28N2O7 | 384.42 | O=C([C@H](C)N[C@H](C(O)=O)CCC1=CC=CC=C1)N2[C@H](C(O)=O)CCC2.O.O |
| EOS-AX6173 | Methylprednisolone Sodium Succinate | 2375-03-3 | C26H33NaO8 | 496.53 | O[C@@]1(C(COC(CCC([O-])=O)=O)=O)[C@](C2)(C)[C@@H](CC1)[C@H](C[C@@H]3C)[C@@H]([C@@](C)(C=C4)C3=CC4=O)[C@H]2O.[Na+] |
| EOS-AX6174 | Sulfisoxazole Acetyl | 80-74-0 | C13H15N3O4S | 309.34 | O=S(C1=CC=C(N([H])[H])C=C1)(N(C(C)=O)C2=C(C)C(C)=NO2)=O |
| EOS-AX6175 | Meglumine Metrizoate | 7241-11-4 | C19H28I3N3O9 | 823.15 | IC(C(N(C(C)=O)C)=C(C(C(O)=O)=C1I)I)=C1NC(C)=O.O[C@H]([C@H](CNC)O)[C@@H]([C@@H](CO)O)O |
| EOS-AX6176 | Tolbutamide Sodium | 473-41-6 | C12H17N2NaO3S | 292.33 | O=S([N-]C(NCCCC)=O)(C1=CC=C(C)C=C1)=O.[Na+] |
| EOS-AX6177 | Tobramycin Sulfate | 49842-07-1 | C18H39N5O13S | 565.59 | OS(O)(=O)=O.O[C@@H]([C@@H]([C@H]1N)O[C@H]([C@@H](C2)N)O[C@H](CN)[C@H]2O)[C@H]([C@@H](C1)N)O[C@H]([C@@H]([C@H]3N)O)O[C@H](CO)[C@H]3O |
| EOS-AX6178 | Mezlocillin Sodium Monohydrate | 80495-46-1 | C21H26N5NaO9S2 | 579.58 | O=C1N2[C@@H]([C@H]1NC([C@H](C3=CC=CC=C3)NC(N(C4=O)CCN4S(=O)(C)=O)=O)=O)SC(C)(C)[C@@H]2C([O-])=O.[Na+].O |
| EOS-AX6179 | Penciclovir Sodium | 97845-62-0 | C10H14N5NaO3 | 275.24 | [O-]C[C@@H](CO)CCN1C(NC(N)=NC2=O)=C2N=C1.[Na+] |
| EOS-AX6180 | Thonzonium Bromide | 553-08-2 | C32H55BrN4O | 591.71 | C[N+](CCN(C1=NC=CC=N1)CC(C=C2)=CC=C2OC)(C)CCCCCCCCCCCCCCCC.[Br-] |
| EOS-AX6181 | Nicotine | 22083-74-5 | C10H14N2 | 162.23 | CN1[C@@H](C2=CC=CN=C2)CCC1 |
| EOS-AX6182 | (-)-epicatechin | 490-46-0 | C15H14O6 | 290.27 | O[C@@H]1CC2=C(C=C(O)C=C2O)O[C@@H]1C3=CC=C(O)C(O)=C3 |
| EOS-AX6183 | (-)-epicatechin gallate | 1257-08-5 | C22H18O10 | 442.37 | OC1=CC(C(O[C@@H]2CC3=C(C=C(O)C=C3O)O[C@@H]2C4=CC=C(O)C(O)=C4)=O)=CC(O)=C1O |
| EOS-AX6184 | (-)-epigallocatechin | 970-74-1 | C15H14O7 | 306.27 | O[C@@H]1CC2=C(C=C(O)C=C2O)O[C@@H]1C3=CC(O)=C(O)C(O)=C3 |
| EOS-AX6185 | ICI 182,780 | 129453-61-8 | C32H47F5O3S | 606.77 | |
| EOS-AX6186 | Rilmenidine Phosphate | 85409-38-7 | C10H19N2O5P | 278.24 | OP(O)(O)=O.C1(NC(C2CC2)C3CC3)=NCCO1 |
| EOS-AX6187 | KN-93 Phosphate | 1188890-41-6 | C26H32ClN2O8PS | 599.03 | CN(C/C=C/C1=CC=C(Cl)C=C1)CC2=CC=CC=C2N(CCO)S(C3=CC=C(OC)C=C3)(=O)=O.O=P(OO)=O.[HH] |
| EOS-AX6188 | HO-3867 | 1172133-28-6 | C28H30F2N2O2 | 464.55 | O=C(/C(CN(CC1=CC(C)(C)N(O[H])C1(C)C)C/2)=C/C3=CC=C(F)C=C3)C2=C\C4=CC=C(F)C=C4 |
| EOS-AX6189 | PTC209 HBr | 1217022-63-3 | C17H13Br2N5OS.HBr | 576.1 | BrC1=CC(OC)=CC(Br)=C1NC2=NC(C3=C(C)N=C4N3C=CC=N4)=CS2.Br |
| EOS-AX6190 | Caspofungin | 162808-62-0 | C53H89N9O15 | 1092.33 | O=C([C@@H]1C[C@@H](O)CN1C([C@@H](NC(C2CC(CCCCCCCCC(C)CC(CC)C)=O)=O)[C@@H](C)O)=O)N[C@@H]([C@H](O)[C@@H](O)C3=CC=C(O)C=C3)C(N[C@@H]([C@H](O)CCN)C(N4CC[C@H](O)[C@H]4C(N[C@@H](NCCN)[C@H](O)C2)=O)=O)=O |
| EOS-AX6191 | Cefpodoxime Proxetil | 87239-81-4 | C21H27N5O9S2 | 557.6 | CC(C)OC(OC(C)OC(C1=C(COC)CS[C@]([H])([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N1C2=O)=O)=O |
| EOS-AX6192 | Cefprozil | 92665-29-7 | C18H19N3O5S | 389.43 | OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@@]2([H])SCC(/C=C/C)=C3C(O)=O)=O)=O)C=C1 |
| EOS-AX6193 | Cetrorelix | 120287-85-6 | C70H92ClN17O14 | 1431.04 | |
| EOS-AX6194 | Desogestrel | 54024-22-5 | C22H30O | 310.47 | [H][C@@]12C(CC[C@]([C@@](CC[C@]3(C#C)O)([H])[C@]3(CC)C4)([H])[C@]2([H])C4=C)=CCCC1 |
| EOS-AX6195 | Enfuvirtide | 159519-65-0 | C204H301N51O64 | 4491.88 | |
| EOS-AX6196 | glatiramer acetate | 147245-92-9 | C25H45N5O13 | 623.65 | OC([C@@H](N)CC1=CC=C(O)C=C1)=O.CC(O)=O.OC([C@@H](N)C)=O.OC(CC[C@H](N)C(O)=O)=O.OC([C@@H](N)CCCCN)=O |
| EOS-AX6197 | Octreotide acetate | 83150-76-9 | C51H70N10O12S2 | 1079.29 | CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O |
| EOS-AX6198 | Pentamidine isethionate | 140-64-7 | C19H24N4O2.2C2H6O4S | 592.68 | NC(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)=N.OCCS(O)(=O)=O.OCCS(O)(=O)=O |
| EOS-AX6199 | Sumatriptan | 103628-46-2 | C14H21N3O2S | 295.4 | CNS(CC1=CC(C(CCN(C)C)=CN2)=C2C=C1)(=O)=O |
| EOS-AX6200 | Topotecan | 123948-87-8 | C23H23N3O5 | 421.45 | CC[C@]1(O)C(C=C2C3=NC4=CC=C(O)C(CN(C)C)=C4C=C3CN2C5=O)=C5COC1=O |
| EOS-AX6201 | GSK-LSD1 2HCl | 1431368-48-7 | C14H22Cl2N2 | 289.24 | C1(N[C@@H]2C[C@H]2C3=CC=CC=C3)CCNCC1 |
| EOS-AX6202 | MI-773 (SAR405838) | 1303607-60-4 | C29H34Cl2FN3O3 | 562.5 | FC1=C(Cl)C=CC=C1[C@@H]2[C@@]3(C(C=CC(Cl)=C4)=C4NC3=O)[C@H](CC(C)(C)C)N[C@H]2C(N[C@@H]5CC[C@@H](O)CC5)=O |
| EOS-AX6203 | CH5183284 (Debio-1347) | 1265229-25-1 | C20H16N6O | 356.38 | CC1=NC(C=C2)=C(N1)C=C2N3N=CC(C(C(N4)=CC5=C4C=CC=C5)=O)=C3N |
| EOS-AX6204 | LY2409881 | 946518-60-1 | C24H32Cl4N6OS | 594.43 | ClC1=CN=C(NCCCN2CCN(C)CC2)N=C1C3=CC4=C(S3)C=CC=C4C(NC5CC5)=O |
| EOS-AX6205 | Liproxstatin-1 | 950455-15-9 | C19H21ClN4 | 340.85 | ClC1=CC(CNC(C2(CCNCC2)N3)=NC4=C3C=CC=C4)=CC=C1 |
| EOS-AX6206 | BRD73954 | 1440209-96-0 | C16H16N2O3 | 284.31 | ONC(C1=CC=CC(C(NCCC2=CC=CC=C2)=O)=C1)=O |
| EOS-AX6207 | EPZ015666 | 1616391-65-1 | C20H25N5O3 | 383.44 | O=C(C1=CC(NC2COC2)=NC=N1)NC[C@@H](O)CN(CC3)CC4=C3C=CC=C4 |
| EOS-AX6208 | Purvalanol A | 212844-53-6 | C19H25ClN6O | 388.89 | ClC1=CC(NC2=C3C(N(C(C)C)C=N3)=NC(N[C@@H](CO)C(C)C)=N2)=CC=C1 |
| EOS-AX6209 | GNE-317 | 1394076-92-6 | C19H22N6O3S | 414.48 | COC1(COC1)C2=C(C)C3=C(S2)C(N4CCOCC4)=NC(C5=CN=C(N)N=C5)=N3 |
| EOS-AX6210 | H-9 dihydrochloride | 116700-36-8 | C11H13N3O2S.2HCl | 324.22 | O=S(NCCN)(C1=CC=CC2=C1C=CN=C2)=O.Cl.Cl |
| EOS-AX6211 | L-693,403 maleate | 137730-52-0 | C20H23N.C4H4O4 | 393.48 | O=C(O)/C([H])=C([H])\C(O)=O.C1(CN2CCC3(CC2)CCC4=CC=CC=C43)=CC=CC=C1 |
| EOS-AX6212 | CCCP | 555-60-2 | C9H5ClN4 | 204.62 | ClC1=CC(N/N=C(C#N)/C#N)=CC=C1 |
| EOS-AX6213 | FCCP | 370-86-5 | C10H5F3N4O | 254.17 | FC(F)(OC1=CC=C(C=C1)N/N=C(C#N)/C#N)F |
| EOS-AX6214 | Flurofamide | 70788-28-2 | C7H9FN3O2P | 217.14 | FC1=CC=C(C=C1)C(NP(N)(N)=O)=O |
| EOS-AX6215 | OR-486 | 7659-29-2 | C6H4N2O6 | 200.11 | OC(C([N+]([O-])=O)=CC([N+]([O-])=O)=C1)=C1O |
| EOS-AX6216 | IPAG | 193527-91-2 | C17H22IN3 | 395.29 | IC1=CC=C(C=C1)N/C(N)=N/[C@@H]2[C@H]3C[C@@H](C4)C[C@@H]2C[C@H]4C3 |
| EOS-AX6217 | 2-Methyl-5-hydroxytryptamine hydrochloride | 845861-49-6 | C11H14N2O.HCl | 226.71 | OC1=CC=C2NC(C)=C(CCN)C2=C1.Cl |
| EOS-AX6218 | Metaphit | 96316-00-6 | C18H24N2S | 300.46 | S=C=NC1=CC(C2(CCCCC2)N3CCCCC3)=CC=C1 |
| EOS-AX6219 | (R)-(-)-α-Methylhistamine dihydrobromide | 868698-49-1 | C6H11N3.2HBr | 287 | N[C@H](C)CC1=CN=CN1.Br.Br |
| EOS-AX6220 | L-690,330 | 142523-38-4 | C8H12O8P2 | 298.13 | OP(O)(C(OC(C=C1)=CC=C1O)(C)P(O)(O)=O)=O |
| EOS-AX6221 | L-690,488 | 142523-14-6 | C32H52O16P2 | 754.7 | CC(C)(C(OCOP(C(OC1=CC=C(O)C=C1)(P(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)=O)C)(OCOC(C(C)(C)C)=O)=O)=O)C |
| EOS-AX6222 | BU 239 hydrochloride | 1217041-98-9 | C11H10N4.HCl | 234.69 | C12=CC=CC=C1N=C(C3=NCCN3)C=N2.Cl |
| EOS-AX6223 | DPPE fumarate | 1185241-83-1 | C19H25NO.C4H4O4 | 399.49 | CCN(CC)CCOC1=CC=C(C=C1)CC2=CC=CC=C2.OC(/C=C/C(O)=O)=O |
| EOS-AX6224 | SIN-1 chloride | 16142-27-1 | C6H11ClN4O2 | 206.63 | N=C1C=N(N2CCOCC2)=NO1.Cl |
| EOS-AX6225 | 2-CMDO | 24140-98-5 | C19H19ClN2O.C4H4O4 | 442.9 | ClC1=CC=C2OC3=CC=CC=C3C=C(C2=C1)N4CC[NH+](C)CC4.OC(/C=C\C([O-])=O)=O |
| EOS-AX6226 | N-MPPP Hydrochloride | 207452-97-9 | C21H26N2O.HCl | 358.91 | CN(C(CC1=CC=CC=C1)=O)[C@](C2=CC=CC=C2)([H])CN3CCCC3.Cl |
| EOS-AX6227 | SB 203186 hydrochloride | 207572-69-8 | C16H20N2O2.HCl | 308.81 | O=C(OCCN1CCCCC1)C2=CNC3=CC=CC=C23.Cl |
| EOS-AX6228 | 7-NINA | 161467-34-1 | C7H4N3O2Na | 185.12 | [O-][N+](C1=C2[N-]N=CC2=CC=C1)=O.[Na+] |
| EOS-AX6229 | ICI 174,864 | 89352-67-0 | C38H53N5O7 | 691.87 | C=CCN([C@@](/C(O)=N/C(C)(/C(O)=N/C(C)(/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CC(C)C)([H])CC1=CC=CC=C1)C)C)([H])CC2=CC=C(O)C=C2)CC=C |
| EOS-AX6230 | Tiotidine | 69014-14-8 | C10H16N8S2 | 312.41 | N/C(N)=N\C1=NC(CSCCN/C(NC#N)=N/C)=CS1 |
| EOS-AX6231 | ICI 154,129 | 83420-94-4 | C34H46N4O6S | 638.83 | O=C([C@H](CC(C=C1)=CC=C1O)N(CC=C)CC=C)NCC(NCCS[C@H](CC2=CC=CC=C2)C(N[C@H](C(O)=O)CC(C)C)=O)=O |
| EOS-AX6232 | Pronethalol hydrochloride | 51-02-5 | C15H19NO.HCl | 265.78 | O[C@H](C1=CC=C2C(C=CC=C2)=C1)CNC(C)C.Cl |
| EOS-AX6233 | ICI 185,282 | 106393-80-0 | C18H21F3O5 | 374.36 | FC(F)([C@@H]1O[C@H](C2=CC=CC=C2O)[C@H](C/C=C\CCCC(O)=O)CO1)F |
| EOS-AX6234 | ICI 192,605 | 117621-64-4 | C22H23ClO5 | 402.87 | ClC1=CC=CC=C1[C@H]2O[C@@H](C3=CC=CC=C3O)[C@@H](C/C=C\CCC(O)=O)CO2 |
| EOS-AX6235 | GR 46611 | 185259-85-2 | C23H27N3O2 | 377.49 | O=C(/C=C\C1=CC=C2NC=C(C2=C1)CCN(C)C)NCC(C=C3)=CC=C3OC |
| EOS-AX6236 | m-CPP hydrochloride | 13078-15-4 | C10H13ClN2.HCl | 233.14 | ClC1=CC(N2CCNCC2)=CC=C1.Cl |
| EOS-AX6237 | Dihydrexidine hydrochloride | 158704-02-0 | C17H17NO2.HCl | 303.79 | OC(C=C1[C@@H]2[C@@H](CCC1=C3)NCC4=CC=CC=C24)=C3O.Cl |
| EOS-AX6238 | RS 45041-190 hydrochloride | 204274-74-8 | C11H12ClN3.HCl | 258.15 | ClC1=CC=CC2=C1CN(C3=NCCN3)C2.Cl |
| EOS-AX6239 | Naltriben mesylate | 122517-78-6 | C26H25NO4.CH3SO3H | 511.59 | OC1=C(O2)C3=C(C[C@]4([H])[C@]5(O)CC(C6=CC=CC=C6O7)=C7[C@@]2([H])[C@]35CCN4CC8CC8)C=C1.CS(O)(=O)=O |
| EOS-AX6240 | Clocinnamox mesylate | 117332-69-1 | C29H29ClN2O4.CH3SO3H | 601.11 | ClC(C=C1)=CC=C1/C=C\C(N[C@]2([C@@H]3N(CC4CC4)CC5)[C@@]5(C6=C(C=C7)C3)[C@H](C(CC2)=O)OC6=C7O)=O.OS(=O)(C)=O |
| EOS-AX6241 | MRS 2179 tetrasodium salt | 1454889-37-2 | C11H13N5O9P2Na4 | 513.16 | CNC1=C(N=CN2[C@@]3([H])C[C@@](OP([O-])([O-])=O)([H])[C@@](O3)([H])COP([O-])([O-])=O)C2=NC=N1.[Na+].[Na+].[Na+].[Na+] |
| EOS-AX6242 | Nociceptin | 170713-75-4 | C79H129N27O22 | 1809 | |
| EOS-AX6243 | SB 205607 dihydrobromide | 148545-09-9 | C23H24N2O.2HBr | 506.28 | CN1CC[C@]2(C3=CC(O)=CC=C3)CC4=NC5=CC=CC=C5C=C4C[C@@]2([H])C1.Br.Br |
| EOS-AX6244 | ICI 215,001 hydrochloride | 141269-99-0 | C19H23NO6.HCl | 397.86 | O[C@@](COC1=CC=CC=C1)([H])CNCCOC2=CC=C(OCC(O)=O)C=C2.Cl |
| EOS-AX6245 | p-Chlorophenylalanine | 7424-00-2 | C9H10ClNO2 | 199.64 | ClC1=CC=C(C=C1)C[C@H](C(O)=O)N |
| EOS-AX6246 | Camstatin | 1002295-95-5 | C122H203N39O34 | 2760.19 | |
| EOS-AX6247 | HU 210 | 112830-95-2 | C25H38O3 | 386.57 | |
| EOS-AX6248 | DCG IV | 147782-19-2 | C7H9NO6 | 203.15 | OC([C@@H]1C([C@@H](C(O)=O)N)[C@H]1C(O)=O)=O |
| EOS-AX6249 | SCH 50911 | 733717-87-8 | C8H15NO3 | 173.21 | OC(C[C@@H]1OCC(C)(C)NC1)=O |
| EOS-AX6250 | RS 67333 hydrochloride | 168986-60-5 | C19H29ClN2O2.HCl | 389.36 | ClC(C=C(C(OC)=C1)C(CCC2CCN(CCCC)CC2)=O)=C1N.Cl |
| EOS-AX6251 | RS 39604 hydrochloride | 167710-87-4 | C26H36ClN3O6S.HCl | 590.56 | ClC(C=C(C(OCC1=CC(OC)=CC(OC)=C1)=C2)C(CCC3CCN(CCNS(=O)(C)=O)CC3)=O)=C2N.Cl |
| EOS-AX6252 | L-745,870 trihydrochloride | 866021-03-6 | C18H19N4Cl.3HCl | 436.21 | ClC1=CC=C(N2CCN(CC3=CNC4=C3C=CC=N4)CC2)C=C1.Cl.Cl.Cl |
| EOS-AX6253 | L-741,742 hydrochloride | 874882-93-6 | C23H25N2ClO.HCl | 417.38 | CC(C(C(CC1)CCN1CCC2=CC=CC=C2)=NO3)=C3C4=CC=C(Cl)C=C4.Cl |
| EOS-AX6254 | Endomorphin-2 | 141801-26-5 | C32H37N5O5 | 571.65 | O=C([C@H]1N(C([C@H](CC(C=C2)=CC=C2O)N)=O)CCC1)N[C@H](C(N[C@H](C(N)=O)CC3=CC=CC=C3)=O)CC4=CC=CC=C4 |
| EOS-AX6255 | Methysergide maleate | 129-49-7 | C21H27N3O2.C4H4O4 | 469.54 | O=C([C@H]1CN(C)[C@H](CC2=CN(C)C3=CC=CC4=C23)C4=C1)N[C@H](CO)CC.OC(/C=C\C(O)=O)=O |
| EOS-AX6256 | ω-Conotoxin MVIIC | 147794-23-8 | C106H178N40O32S7 | 2749 | |
| EOS-AX6257 | ω-Conotoxin GVIA | 106375-28-4 | C120H182N38O43S6 | 3037 | |
| EOS-AX6258 | [Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2 | 213130-17-7 | C61H102N22O14 | 1367.6 | |
| EOS-AX6259 | ACPT-I | 194918-76-8 | C8H11NO6 | 217.18 | OC([C@]1(C[C@@H](C(O)=O)[C@@H](C(O)=O)C1)N)=O |
| EOS-AX6260 | Nocistatin (bovine) | 208253-85-4 | C82H135N21O32 | 1927.07 | |
| EOS-AX6261 | NocII | 188119-47-3 | C92H141N23O28S2 | 2081.4 | |
| EOS-AX6262 | Picrotoxin | 124-87-8 | C30H34O13 | 602.59 | |
| EOS-AX6263 | L-NIL hydrochloride | 150403-89-7 | C8H17N3O2.HCl | 223.7 | OC([C@H](CCCC/N=C(C)/N)N)=O.Cl |
| EOS-AX6264 | L-733,060 hydrochloride | 148687-76-7 | C20H19F6NO.HCl | 439.83 | FC(F)(C1=CC(C(F)(F)F)=CC(CO[C@H]2[C@@H](C3=CC=CC=C3)NCCC2)=C1)F.Cl |
| EOS-AX6265 | Bombesin | 31362-50-2 | C71H110N24O18S | 1619 | |
| EOS-AX6266 | CCK Octapeptide, non-sulfated | 25679-24-7 | C49H62N10O13S2 | 1063 | O=C([C@H](CCSC)NC([C@@H](CC(O)=O)NC([C@@H](CC1=CC=CC=C1)NN)=O)=O)N[C@H](C(NCC(N[C@@H](C(N[C@@H](C(C([C@@H](CC(O)=O)N)=O)=O)CC(C=C2)=CC=C2O)=O)CCSC)=O)=O)CC3=CNC4=CC=CC=C34 |
| EOS-AX6267 | CRF (human, rat) | 86784-80-7 | C208H344N60O63S2 | 4758 | |
| EOS-AX6268 | Pancreatic Polypeptide (human) | 75976-10-2 | C185H287N53O54S2 | 4181.7 | |
| EOS-AX6269 | CGRP (rat) | 83651-90-5 | C162H262N50O52S2 | 3807 | |
| EOS-AX6270 | Endothelin 3 (human, rat) | 117399-93-6 | C121H168N26O33S4 | 2643 | |
| EOS-AX6271 | Saralasin | 34273-10-4 | C42H65N13O10 | 912 | O=C([C@@H](CC1=CN=CN1)NC([C@@H](C(C)C)NC([C@H](CC(C=C2)=CC=C2O)NC([C@H](C(C)C)NC([C@H](CCC/N=C(N)\N)NC(CNC)=O)=O)=O)=O)=O)N3[C@@H](C(N[C@H](C(O)=O)C)=O)CCC3 |
| EOS-AX6272 | Somatostatin 1-28 | 74315-46-1 | C137H207N41O39S3 | 3149 | |
| EOS-AX6273 | [Leu31,Pro34]-Neuropeptide Y (porcine) | 125580-28-1 | C190H286N54O56 | 4223 | |
| EOS-AX6274 | CGRP 8-37 (rat) | 129121-73-9 | C138H224N42O41 | 3127.5 | |
| EOS-AX6275 | DSLET | 75644-90-5 | C33H46N6O10 | 686.9 | O=C([C@@H](CC(C)C)NC([C@H](CC1=CC=CC=C1)NC(CNC([C@H](CO)NC([C@H](CC(C=C2)=CC=C2O)N)=O)=O)=O)=O)N[C@H](C(O)=O)[C@@H](C)O |
| EOS-AX6276 | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | 93965-89-0 | C157H252N44O43S | 3475 | |
| EOS-AX6277 | Sarafotoxin S6b | 116303-65-2 | C110H159N27O34S5 | 2564 | |
| EOS-AX6278 | Sarafotoxin S6c | 121695-87-2 | C103H147N27O37S5 | 2516 | |
| EOS-AX6279 | [Leu31,Pro34]-Neuropeptide Y (human, rat) | 132699-73-1 | C189H284N54O56S | 4241 | |
| EOS-AX6280 | [D-Ala2]-Deltorphin II | 122752-16-3 | C38H54N8O10 | 782.89 | O=C([C@@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H](CC1=CC=CC=C1)NC([C@@H](C)NC([C@H](CC(C=C2)=CC=C2O)N)=O)=O)=O)=O)N[C@H](C(NCC(N)=O)=O)C(C)C |
| EOS-AX6281 | CGRP 8-37 (human) | 119911-68-1 | C139H230N44O38 | 3125.64 | |
| EOS-AX6282 | VIP (guinea pig) | 96886-24-7 | C147H239N43O42S2 | 3346 | |
| EOS-AX6283 | PACAP 1-27 | 127317-03-7 | C142H224N40O39S | 3147.6 | |
| EOS-AX6284 | α-helical CRF 9-41 | 90880-23-2 | C166H274N46O53S2 | 3827 | |
| EOS-AX6285 | BQ-3020 | 143113-45-5 | C96H140N20O25S | 2006.35 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C)([H])CC(C)C)([H])CCSC)([H])CC(O)=O)([H])CCCCN)([H] |
| EOS-AX6286 | MDL 29,913 | 135721-56-1 | C40H56N8O6 | 745 | O=C([C@H](CC(C)C)N(C)C[C@@H](CC(C)C)N)N[C@H](C(N[C@H](C(N[C@H](C(/N=C\C=O)=O)CC1=CC=CC=C1)=O)CC2=CNC3=CC=CC=C23)=O)CCC(N)=O |
| EOS-AX6287 | IRL-1038 | 144602-02-8 | C68H92N14O15S2 | 1410 | |
| EOS-AX6288 | [Ala1,3,11,15]-Endothelin | 121204-87-3 | C109H163N25O32S | 2368 | |
| EOS-AX6289 | Nocistatin (human) | 212609-11-5 | C149H238N42O53S3 | 3561.93 | |
| EOS-AX6290 | FR 139317 | 142375-60-8 | C33H44N6O5 | 604.75 | O=C(N[C@H](C(N[C@@H](C(N[C@@H](C(O)=O)CC1=NC=CC=C1)=O)CC2=CN(C)C3=CC=CC=C23)=O)CC(C)C)N4CCCCCC4 |
| EOS-AX6291 | ZD 7155 hydrochloride | 146709-78-6 | C26H26N6O.HCl | 474.99 | O=C1N(CC2=CC=C(C3=CC=CC=C3C4=NNN=N4)C=C2)C5=C(C(CC)=NC(CC)=C5)CC1.Cl |
| EOS-AX6292 | DL-TBOA | 205309-81-5 | C11H13NO5 | 239.23 | OC([C@H]([C@@H](C(O)=O)N)OCC1=CC=CC=C1)=O |
| EOS-AX6293 | Ac-RYYRIK-NH2 | 200959-48-4 | C44H70N14O9 | 939.12 | O=C([C@H]([C@@H](C)CC)NC([C@H](CCC/N=C(N)\N)NC([C@H](CC(C=C1)=CC=C1O)NC([C@H](CC(C=C2)=CC=C2O)NC([C@H](CCC/N=C(N)\N)NC(C)=O)=O)=O)=O)=O)N[C@H](C(N)=O)CCCCN |
| EOS-AX6294 | CGP 55845 hydrochloride | 149184-22-5 | C18H22Cl2NO3P.HCl | 438.71 | C[C@@](NC[C@@](O)([H])CP(CC1=CC=CC=C1)(O)=O)([H])C2=CC(Cl)=C(Cl)C=C2.Cl |
| EOS-AX6295 | Nociceptin (1-7) | 178249-42-8 | C31H41N7O9 | 655.7 | O[C@H](C)[C@@H](C(NCC(N[C@H](C(O)=O)C)=O)=O)NC([C@H](CC1=CC=CC=C1)NC(CNC(CNC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O |
| EOS-AX6296 | 2-Arachidonylglycerol | 53847-30-6 | C23H38O4 | 378.55 | |
| EOS-AX6297 | [Nphe1]Nociceptin(1-13)NH2 | 267234-08-2 | C61H100N22O15 | 1381.6 | |
| EOS-AX6298 | Tertiapin-Q | 252198-49-5 | C100H163N31O23S4 | 2295.82 | |
| EOS-AX6299 | RS 100329 hydrochloride | 1215654-26-4 | C20H25F3N4O3.HCl | 462.89 | CC(C1=O)=CN=C(O)N1CCCN2CCN(C3=CC=CC=C3OCC(F)(F)F)CC2.Cl |
| EOS-AX6300 | Ryanodine | 15662-33-6 | C25H35NO9 | 493.55 | O[C@@]1([C@@]([C@]2(C)C3)([C@H]4OC(C5=CC=CN5)=O)O)[C@]([C@@]4(C(C)C)O)(C)[C@]3(O)O[C@]1([C@@H]6O)[C@]2(CC[C@H]6C)O |
| EOS-AX6301 | α-Conotoxin MII | 175735-93-0 | C67H103N23O22S4 | 1710.99 | |
| EOS-AX6302 | JWH 015 | 155471-08-2 | C23H21NO | 327.43 | O=C(C1=CC=CC2=CC=CC=C12)C3=C(C)N(CCC)C4=CC=CC=C43 |
| EOS-AX6303 | JWH 018 | 209414-07-3 | C24H23NO | 341.45 | |
| EOS-AX6304 | JWH 133 | 259869-55-1 | C22H32O | 312.49 | |
| EOS-AX6305 | SAMS Peptide | 125911-68-4 | C74H131N29O18S2 | 1779.15 | |
| EOS-AX6306 | des-Gln14-Ghrelin (rat) | 293735-04-3 | C142H237N43O40 | 3186.7 | |
| EOS-AX6307 | UB 165 fumarate | 200432-86-6 | C13H15ClN2.C4H4O4 | 350.8 | ClC1=NC=C(C2=CCC[C@]3([H])CC[C@@]2([H])N3)C=C1.O=C(O)/C([H])=C([H])/C([*])=O |
| EOS-AX6308 | Phospho-Glycogen Synthase Peptide-2 (substrate) | 851366-97-7 | C123H191N40O48P | 3029 | |
| EOS-AX6309 | Akt/SKG Substrate Peptide | 276680-69-4 | C36H59N13O9 | 817.95 | |
| EOS-AX6310 | Nociceptin (1-13)NH2 | 178064-02-3 | C61H100N22O15 | 1381.6 | |
| EOS-AX6311 | [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] - hPancreatic Polypeptide | 313988-89-5 | C183H281N57O54S2 | 4207.67 | |
| EOS-AX6312 | SB 200646 hydrochloride | 143797-62-0 | C15H14N4O.HCl | 302.76 | O=C(NC1=CC=CN=C1)NC2=CC=C3N(C)C=CC3=C2.Cl |
| EOS-AX6313 | SB 204070 | 148688-01-1 | C19H27ClN2O4.HCl | 419.34 | ClC1=C(C2=C(C(C(OCC3CCN(CCCC)CC3)=O)=C1)OCCO2)N.Cl |
| EOS-AX6314 | MRS 1334 | 192053-05-7 | C31H26N2O6 | 522.56 | O=C(C1=C(C2=CC=CC=C2)NC(C)=C(C(OCC)=O)[C@H]1C#CC3=CC=CC=C3)OCC4=CC=CC([N+]([O-])=O)=C4 |
| EOS-AX6315 | [Ala11,22,28]VIP | 291524-04-4 | C139H231N43O39S | 3160.68 | |
| EOS-AX6316 | Ac-RYYRWK-NH2 | 200959-47-3 | C49H69N15O9 | 1012.17 | C/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CCCCN)([H])CC1=CNC2=CC=CC=C12)([H])CCCNC(N)=N)([H])CC3=CC=C(O)C=C3)([H])CC4=CC=C(O)C=C4)([H])CCCNC(N)=N |
| EOS-AX6317 | Noladin ether | 222723-55-9 | C23H40O3 | 364.57 | OCC(CO)OCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC |
| EOS-AX6318 | Naloxone benzoylhydrazone | 119630-94-3 | C26H27N3O4 | 445.52 | O[C@@]([C@@H]1N(CC=C)CC2)(CC/C3=N\NC(C4=CC=CC=C4)=O)[C@@]2(C5=C(C=C6)C1)[C@H]3OC5=C6O |
| EOS-AX6319 | DPDPE | 88373-73-3 | C30H39N5O7S2 | 645.79 | O=C1NCC(N[C@H](CC2=CC=CC=C2)C(N[C@@H](C(O)=O)C(C)(C)SSC(C)(C)[C@@H]1NC([C@@H](CC(C=C3)=CC=C3O)N)=O)=O)=O |
| EOS-AX6320 | BMY 14802 hydrochloride | 105565-55-7 | C18H22F2N4O.HCl | 384.86 | FC1=CN=C(N=C1)N2CCN(CCC[C@H](C(C=C3)=CC=C3F)O)CC2.Cl |
| EOS-AX6321 | BMS 182874 hydrochloride | 1215703-04-0 | C17H19N3O3S.HCl | 381.88 | CC(C(C)=NO1)=C1NS(C2=CC=CC3=C2C=CC=C3N(C)C)(=O)=O.Cl |
| EOS-AX6322 | Metastin (human) | 374683-24-6 | C258H401N79O78 | 5857.49 | |
| EOS-AX6323 | Galanin (1-15) (porcine, rat) | 112747-70-3 | C72H105N19O20 | 1556.74 | |
| EOS-AX6324 | Galanin (2-29) (rat) | 141696-11-9 | C144H210N42O39 | 3153.47 | |
| EOS-AX6325 | Orexin A (human, rat, mouse) | 205640-90-0 | C152H247N47O44S4 | 3565.14 | |
| EOS-AX6326 | Orexin B (human) | 205640-91-1 | C123H212N44O35S | 2899.36 | |
| EOS-AX6327 | Orexin B (mouse) | 202801-92-1 | C126H215N45O34S | 2936.43 | |
| EOS-AX6328 | Ghrelin (rat) | 258338-12-4 | C147H245N45O42 | 3314.83 | |
| EOS-AX6329 | Proglumide sodium salt | 99247-33-3 | C18H25N2NaO4 | 356.39 | O=C([C@@H](CCC([O-])=O)NC(C1=CC=CC=C1)=O)N(CCC)CCC.[Na+] |
| EOS-AX6330 | (-)-5'-DMH-CBD | 97452-63-6 | C25H38O2 | 370.57 | CCCCCCC(C)(C(C=C1O)=CC(O)=C1[C@]2([H])C=C(CC[C@@]2([H])C(C)=C)C)C |
| EOS-AX6331 | tcY-NH2 | 327177-34-4 | C40H49N7O7 | 739.87 | O=C([C@H](CC(C=C1)=CC=C1O)NC(/C=C/C2=CC=CC=C2)=O)N3[C@H](C(NCC(N[C@H](C(N[C@H](C(N)=O)CC4=CC=CC=C4)=O)CCCCN)=O)=O)CCC3 |
| EOS-AX6332 | LY 233053 | 125546-04-5 | C8H13N5O2 | 211.22 | OC([C@H]1NCC[C@@H](CC2=NNN=N2)C1)=O |
| EOS-AX6333 | LY 288513 | 147523-65-7 | C22H18BrN3O2 | 436.3 | BrC1=CC=C(NC(N2[C@@]([C@](C(O)=N2)([H])C3=CC=CC=C3)([H])C4=CC=CC=C4)=O)C=C1 |
| EOS-AX6334 | 10Z-Hymenialdisine | 82005-12-7 | C11H10BrN5O2 | 324.13 | BrC1=CC(/C(CCNC2=O)=C3NC(N)=NC/3=O)=C2N1 |
| EOS-AX6335 | Hemokinin 1 (mouse) | 208041-90-1 | C61H100N22O15S | 1413.66 | |
| EOS-AX6336 | UFP-101 | 849024-68-6 | C82H138N32O21 | 1908.19 | |
| EOS-AX6337 | CTAP | 103429-32-9 | C51H69N13O11S2 | 1104.32 | |
| EOS-AX6338 | JIP-1 (153-163) | 438567-88-5 | C61H104N20O14 | 1341.6 | |
| EOS-AX6339 | [(pF)Phe4]Nociceptin(1-13)NH2 | 380620-88-2 | C61H95F5N22O15 | 1471.54 | |
| EOS-AX6340 | NADA | 199875-69-9 | C28H41NO3 | 439.64 | |
| EOS-AX6341 | (-)-Cannabidiol | 13956-29-1 | C21H30O2 | 314.47 | |
| EOS-AX6342 | L-R4W2 | 206350-79-0 | C46H71N21O6 | 1014.2 | N[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CC1=CNC2=CC=CC=C12)([H])CC3=CNC4=CC=CC=C34)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N |
| EOS-AX6343 | CTOP | 103429-31-8 | C50H67N11O11S2 | 1062.28 | |
| EOS-AX6344 | [Arg14,Lys15]Nociceptin | 236098-40-1 | C82H137N31O22 | 1909.18 | |
| EOS-AX6345 | pep2m | 243843-42-7 | C49H92N18O13S | 1173.44 | CC([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCCN)([H])CCCNC(N)=N)([H])CCSC)([H])CCCCN)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCC(O)=N)([H])C)([H])CC(O)=N)([H])CCCCN)([H])C)C |
| EOS-AX6346 | pep4c | 243843-43-8 | C48H91N17O13S | 1146.42 | CC([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCCN)([H])CCCNC(N)=N)([H])CCSC)([H])CCCCN)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCC(O)=N)([H])C)([H])CO)([H])CCCCN)([H])C)C |
| EOS-AX6347 | pep2-SVKI | 328944-75-8 | C60H93N13O18 | 1284.47 | |
| EOS-AX6348 | pep2-SVKE | 1315378-76-7 | C59H89N13O20 | 1300.43 | |
| EOS-AX6349 | pep2-EVKI | 1315378-67-6 | C62H95N13O19 | 1326.51 | |
| EOS-AX6350 | pep2-AVKI | 1315378-69-8 | C60H93N13O17 | 1268.47 | |
| EOS-AX6351 | Pep1-TGL | C41H71N11O15S | 990.14 | CC(CC(NC(C1CCCN1C(C(NC(CNC(C(NC(C(N)CO)=O)CO)=O)=O)CCSC)=O)=O)C(NCC(NC(C(NC(C(NCC(NC(C(O)=O)CC(C)C)=O)=O)C(O)C)=O)C)=O)=O)C | |
| EOS-AX6352 | Pep1-AGL | C40H69N11O14S | 960.11 | CC(CC(NC(C1CCCN1C(C(NC(CNC(C(NC(C(N)CO)=O)CO)=O)=O)CCSC)=O)=O)C(NCC(NC(C(NC(C(NCC(NC(C(O)=O)CC(C)C)=O)=O)C)=O)C)=O)=O)C | |
| EOS-AX6353 | Urocortin (human) | 176591-49-4 | C204H337N63O64 | 4696.29 | |
| EOS-AX6354 | Urocortin (rat) | 171543-83-2 | C206H338N62O64 | 4707.31 | |
| EOS-AX6355 | Astressin | 170809-51-5 | C161H269N49O42 | 3563.2 | |
| EOS-AX6356 | CRF (6-33) | 120066-38-8 | C141H231N41O43S | 3220.68 | |
| EOS-AX6357 | Stressin I | C203H337N57O56 | 4472.24 | ||
| EOS-AX6358 | Sauvagine | 74434-59-6 | C202H346N56O63S | 4599.35 | |
| EOS-AX6359 | [Orn8]-Urotensin II | 479065-85-5 | C63H83N13O18S2 | 1374.54 | |
| EOS-AX6360 | 2-Methylthioadenosine diphosphate trisodium salt | 475193-31-8 | C11H14N5Na3O10P2S | 539.24 | CSC1=NC(N)=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP([O-])(OP([O-])([O-])=O)=O)C2=N1.[Na+].[Na+].[Na+] |
| EOS-AX6361 | Y-29794 oxalate | 146794-84-5 | C23H34N2OS2.C2H2O4 | 508.69 | O=C(C1=CC=CS1)C2=CC=C(C(C)C)N=C2SCCCCCCCCN(C)C.OC(C(O)=O)=O |
| EOS-AX6362 | Urotensin II (human) | 251293-28-4 | C64H85N13O18S2 | 1388.57 | |
| EOS-AX6363 | BAM 22P | 76622-26-9 | C130H184N38O31S2 | 2839.24 | CC([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/C/N=C(O)/[C@](N)([H])CC1=CC=C(O)C=C1)([H])CC2=CC=CC=C2)([H])CCSC)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])/C(O)=N/C/C(O)=N/[C@@](C(N3CCC[C@@]3([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)= |
| EOS-AX6364 | O-2050 | C23H31NO4S | 417.56 | OC1=C2[C@@H]3[C@@H](CC=C(C)C3)C(C)(C)OC2=CC(CC#CCCCNS(=O)(C)=O)=C1 | |
| EOS-AX6365 | BW 373U86 | 155836-50-3 | C27H37N3O2 | 435.61 | OC1=CC([C@@H](C2=CC=C(C(N(CC)CC)=O)C=C2)N3[C@@H](C)CN(CC=C)[C@H](C)C3)=CC=C1 |
| EOS-AX6366 | GR 94800 | 141636-65-9 | C49H61N9O8 | 904.08 | O=C([C@@H]1N(C([C@H](CC2=CC=CC=C2)NC([C@@H](CC3=CNC4=CC=CC=C34)NC([C@H](C)NC([C@H](C)NC(C5=CC=CC=C5)=O)=O)=O)=O)=O)CCC1)N6[C@H](C(N[C@H](C(N)=O)CCCC)=O)CCC6 |
| EOS-AX6367 | GR 64349 | 137593-52-3 | C42H68N10O11S | 921.12 | |
| EOS-AX6368 | GR 73632 | 133156-06-6 | C40H59N7O6S | 766.01 | O=C([C@H]1N(C([C@H](CC2=CC=CC=C2)NC([C@H](CC3=CC=CC=C3)NC(CCCCN)=O)=O)=O)CCC1)N(C)[C@H](C(N[C@H](C(N)=O)CCSC)=O)CC(C)C |
| EOS-AX6369 | GR 82334 | 129623-01-4 | C69H91N15O16 | 1386.57 | |
| EOS-AX6370 | T 0156 hydrochloride | 324572-93-2 | C31H29N5O7.HCl | 620.06 | CC1=CC(CN2C(C(OC)=O)=C(C3=CC=NC(OCC4=NC=CC=N4)=C3C2=O)C5=CC(OC)=C(OC)C(OC)=C5)=CC=N1.Cl |
| EOS-AX6371 | NECA | 35920-39-9 | C12H16N6O4 | 308.3 | O[C@H]1[C@@H](N2C3=NC=NC(N)=C3N=C2)O[C@H](C(NCC)=O)[C@H]1O |
| EOS-AX6372 | Ionomycin calcium salt | 56092-82-1 | C41H70O9.Ca | 747.08 | O[C@H](C)[C@@]1(C)O[C@H](CC1)[C@]2(C)O[C@@H](C[C@@H]([C@@H](C)[C@H]([C@H](/C=C/C[C@@H](C)C[C@@H](C)/C([O-])=C\C([C@@H](C)C[C@@H](C)C[C@@H](C)CCC([O-])=O)=O)C)O)O)CC2.[Ca+2] |
| EOS-AX6373 | BAM (8-22) | 412961-36-5 | C91H127N25O23S | 1971.22 | |
| EOS-AX6374 | Hemopressin (rat) | 568588-77-2 | C53H77N13O12 | 1088.27 | |
| EOS-AX6375 | Spantide I | 91224-37-2 | C75H108N20O13 | 1497.8 | |
| EOS-AX6376 | GRP (porcine) | 74815-57-9 | C126H198N38O31S2 | 2805.31 | |
| EOS-AX6377 | GRP (human) | 93755-85-2 | C130H204N38O31S2 | 2859.4 | |
| EOS-AX6378 | Pseudo RACK1 | C144H225N43O34S3 | 3198.81 | ||
| EOS-AX6379 | PKC ζ pseudosubstrate | C208H336N74O44S3 | 4673.59 | ||
| EOS-AX6380 | PKC β pseudosubstrate | 172308-76-8 | C177H294N62O38S3 | 3994.84 | |
| EOS-AX6381 | AF 12198 | 185413-30-3 | C96H123N19O22 | 1895.14 | CC(C[C@@](/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@]2([H])CCN2C([C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@]3([H])CCCN3C([C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C)([H])CC4=CC=CC=C4)([H])CCC(O)=O)([H])CC5=CNC6= |
| EOS-AX6382 | Ro 26-4550 trifluoroacetate | 1217448-66-2 | C26H30N4O3.CF3CO2H | 560.57 | OC(C(F)(F)F)=O.NC(N1CCC[C@H](CC(N[C@H](C(OC)=O)CC2=CC=C(C#CC3=CC=CC=C3)C=C2)=O)C1)=N |
| EOS-AX6383 | OMDM-2 | 616884-63-0 | C27H45NO3 | 431.66 | O=C(CCCCCCC/C=C/CCCCCCCC)N[C@@H](CO)CC(C=C1)=CC=C1O |
| EOS-AX6384 | WKYMVM | 187986-11-4 | C41H61N9O7S2 | 856.11 | O=C([C@H](CCCCN)NC([C@H](CC1=CNC2=CC=CC=C12)N)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(N)=O)CCSC)=O)C(C)C)=O)CCSC)=O)CC(C=C3)=CC=C3O |
| EOS-AX6385 | WKYMVm | 187986-17-0 | C41H61N9O7S2 | 856.11 | O=C([C@H](CCCCN)NC([C@H](CC1=CNC2=CC=CC=C12)N)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(N)=O)CCSC)=O)C(C)C)=O)CCSC)=O)CC(C=C3)=CC=C3O |
| EOS-AX6386 | 2B-(SP) | 186901-17-7 | C71H123N26O29P | 1835.88 | |
| EOS-AX6387 | Threo-methylphenidate hydrochloride | 298-59-9 | C14H19NO2.HCl | 269.77 | O=C([C@@H](C1=CC=CC=C1)[C@H]2NCCCC2)OC.Cl |
| EOS-AX6388 | HS 014 | 207678-81-7 | C71H94N20O17S2 | 1563.77 | |
| EOS-AX6389 | HS 024 | 212370-59-7 | C58H79N19O10S2 | 1266.5 | CCCC[C@@](/N=C(O)/[C@](/N=C(O)/C)([H])CS)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](C(O)=N)([H])CS)([H])CC1=CNC2=CC=CC=C12)([H])CCCNC(N)=N)([H])CC3=CC4=CC=CC=C4C=C3)([H])CC5=CN=CN5)([H])CCCNC(N)=N |
| EOS-AX6390 | FRATide | 251087-38-4 | C192H327N67O60 | 4534.11 | |
| EOS-AX6391 | BIM 23127 | 160161-61-5 | C62H71N11O9S2 | 1178.43 | CC([C@@]1([H])/C(O)=N/[C@@](/C(O)=N/[C@](C(O)=N)([H])CC2=CC3=CC=CC=C3C=C2)([H])CSSC[C@@](/N=C(O)/[C@@](N)([H])CC4=CC5=CC=CC=C5C=C4)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/1)([H])CCCN)([H])CC6=CNC7=CC=CC=C67)([H])CC8=CC=C(O)C=C8)C |
| EOS-AX6392 | CYN 154806 | 183658-72-2 | C56H68N12O14S2 | 1197.35 | C[C@](O)([H])[C@@]1([H])/C(O)=N/[C@@](/C(O)=N/[C@](C(O)=N)([H])CC2=CC=C(O)C=C2)([H])CSSC[C@](/N=C(O)/[C@](/N=C(O)/C)([H])CC3=CC=C(N(=O)=O)C=C3)([H])/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/[C@@](/C(O)=N/1)([H])CCCCN)([H])CC4=CNC5=CC=CC=C45)([H])CC6=CC=C(O)C=C6 |
| EOS-AX6393 | BIM 23056 | 150155-61-6 | C71H81N11O9 | 1232.49 | CC([C@@](/N=C(O)/[C@](/N=C(O)/[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@@](N)([H])CC1=CC=CC=C1)([H])CC2=CC=CC=C2)([H])CC3=CC=C(O)C=C3)([H])CC4=CNC5=CC=CC=C45)([H])CCCCN)([H])/C(O)=N/[C@@](/C(O)=N/[C@](C(O)=N)([H])CC6=CC7=CC=CC=C7C=C6)([H])CC8=CC=CC=C8)C |
| EOS-AX6394 | Ac2-26 | 151988-33-9 | C141H210N32O44S | 3089.46 | |
| EOS-AX6395 | Ac2-12 | 256447-08-2 | C63H94N14O17S | 1351.58 | |
| EOS-AX6396 | Glucagon-like peptide 1 (1-37) (human, rat) | 87805-34-3 | C186H275N51O59 | 4169.52 | |
| EOS-AX6397 | MLCK inhibitor peptide 18 | 224579-74-2 | C60H105N23O11 | 1324.64 | NCCCC[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCNC(N)=N)([H])CCCCN)([H])CCCCN)([H])CC1=CC=C(O)C=C1)([H])CCCCN)([H])CC2=CC=C(O)C=C2)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])C(O)=N |
| EOS-AX6398 | Neuropeptide SF (human) | 192387-39-6 | C65H94N18O15 | 1367.57 | |
| EOS-AX6399 | PKC fragment (530-558) | 122613-29-0 | C148H221N35O50S2 | 3354.7 | |
| EOS-AX6400 | [Leu5]-Enkephalin | 58822-25-6 | C28H37N5O7 | 555.63 | O=C([C@@H](CC1=CC=CC=C1)NC(CNC(CNC([C@H](CC(C=C2)=CC=C2O)N)=O)=O)=O)N[C@H](C(O)=O)CC(C)C |
| EOS-AX6401 | Neuromedin C (porcine) | 81608-30-2 | C50H73N17O11S | 1120.29 | |
| EOS-AX6402 | Mastoparan X | 72093-22-2 | C73H126N20O15S | 1555.98 | |
| EOS-AX6403 | Sarafotoxin S6a | 126738-34-9 | C105H156N28O34S5 | 2514.85 | |
| EOS-AX6404 | [Ala107]-MBP (104-118) | 99026-77-4 | C67H104N20O19 | 1493.68 | |
| EOS-AX6405 | [Ala113]-MBP (104-118) | 99026-78-5 | C67H104N20O19 | 1493.68 | |
| EOS-AX6406 | [Ala92]-p16 (84-103) | 189064-08-2 | C93H155N31O26 | 2123.44 | |
| EOS-AX6407 | VIP (6-28) (human, rat, porcine, bovine) | 69698-54-0 | C126H207N37O34S | 2816.31 | |
| EOS-AX6408 | Atrial natriuretic factor (1-28) (human, porcine) | 91917-63-4 | C127H205N45O39S3 | 3080.46 | |
| EOS-AX6409 | Neuromedin N (rat, mouse, porcine, canine) | 92169-45-4 | C38H63N7O8 | 745.96 | O=C([C@H]([C@H](C)CC)NC([C@@H](CCCCN)N)=O)N1[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CC(C)C)=O)[C@H](C)CC)=O)CC(C=C2)=CC=C2O)=O)CCC1 |
| EOS-AX6410 | Neuromedin B (porcine) | 87096-84-2 | C52H73N15O12S | 1132.3 | |
| EOS-AX6411 | Neurotensin | 39379-15-2 | C78H121N21O20 | 1672.94 | |
| EOS-AX6412 | Atrial natriuretic factor (1-28) (rat) | 88898-17-3 | C128H205N45O39S2 | 3062.43 | |
| EOS-AX6413 | [D-Phe12]-Bombesin | 108437-87-2 | C74H112N22O18S | 1629.9 | |
| EOS-AX6414 | Kinetensin (human) | 103131-69-7 | C56H85N17O11 | 1172.39 | |
| EOS-AX6415 | Litorin | 55749-97-8 | C51H68N14O11S | 1085.25 | O=C([C@H](CC1)NC1=O)N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCSC)=O)CC2=CC=CC=C2)=O)CC3=CNC=N3)=O)=O)C(C)C)=O)=O)CC4=CNC5=CC=CC=C45)=O)CCC(N)=O |
| EOS-AX6416 | Neuromedin U (rat) | 117505-80-3 | C124H180N34O31 | 2643 | |
| EOS-AX6417 | Secretin (rat) | 121028-49-7 | C129H216N42O42 | 3027.38 | |
| EOS-AX6418 | Eledoisin-Related Peptide | 2990-43-4 | C34H58N8O6S | 706.94 | O=C([C@H]([C@@H](C)CC)NC([C@H](CC1=CC=CC=C1)NC([C@H](CCCCN)N)=O)=O)NCC(N[C@H](C(N[C@H](C(N)=O)CCSC)=O)CC(C)C)=O |
| EOS-AX6419 | [D-Lys3]-GHRP-6 | 136054-22-3 | C49H63N13O6 | 930.12 | NCCCC[C@@](/N=C(O)/[C@@](/N=C(O)/[C@](/N=C(O)/[C@@](/N=C(O)/[C@@](/N=C(O)/[C@](N)([H])CC1=CN=CN1)([H])CC2=CNC3=CC=CC=C23)([H])CCCCN)([H])CC4=CNC5=CC=CC=C45)([H])CC6=CC=CC=C6)([H])C(O)=N |
| EOS-AX6420 | pp60 c-src (521-533) (phosphorylated) | 149299-77-4 | C62H95N16O28P | 1543.5 | |
| EOS-AX6421 | MLCK inhibitor peptide | 198694-74-5 | C68H113N23O12 | 1444.79 | |
| EOS-AX6422 | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | 159439-02-8 | C32H46N5O17P | 803.71 | O=C([C@H]([C@@H](C)CC)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC(C=C1)=CC=C1OP(O)(O)=O)NC(C)=O)=O)=O)=O)N[C@H](C(O)=O)CCC(O)=O |
| EOS-AX6423 | Neuropeptide AF (human) | 192387-38-5 | C90H132N26O25 | 1978.19 | |
| EOS-AX6424 | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide | 190078-50-3 | C26H42N3O9P | 571.61 | O=C([C@H](CCC(O)=O)NC([C@H](CC(C=C1)=CC=C1OP(O)(O)=O)NC(C)=O)=O)N(CCCCC)CCCCC |
| EOS-AX6425 | C14TKL-1 | C63H98N20O13S2 | 1406.7 | ||
| EOS-AX6426 | PR 39 (porcine) | 139637-11-9 | C229H346N70O40 | 4719.7 | |
| EOS-AX6427 | L-670,596 | 121083-05-4 | C22H21F2NO4S | 433.47 | FC1=C2N(CC(C=C3)=CC=C3S(=O)(C)=O)C4=C(C2=CC(F)=C1)CCC[C@@H]4CC(O)=O |
| EOS-AX6428 | Antagonist G | 115150-59-9 | C49H66N12O6S | 951.2 | O=C([C@H](CC1=CC=CC=C1)N(C)C([C@@H](CC2=CNC3=CC=CC=C23)NC([C@H](CCC/N=C(N)\N)N)=O)=O)N[C@@H](C(N[C@H](C(N[C@H](C(N)=O)CCSC)=O)CC(C)C)=O)CC4=CNC5=CC=CC=C45 |
| EOS-AX6429 | Norketamine hydrochloride | 79499-59-5 | C12H14ClNO.HCl | 260.16 | ClC1=CC=CC=C1[C@]2(CCCCC2=O)N.Cl |
| EOS-AX6430 | 6-Iodonordihydrocapsaicin | 859171-97-4 | C17H26INO3 | 419.3 | IC(C=C1O)=C(C=C1OC)CNC(CCCCCCCC)=O |
| EOS-AX6431 | 740 Y-P | 1236188-16-1 | C141H222N43O39PS3 | 3270.72 | |
| EOS-AX6432 | Nogo-66 (1-40) | 475221-20-6 | C206H324N56O65 | 4625.16 | |
| EOS-AX6433 | JMV 449 | 139026-66-7 | C38H66N8O7 | 746.96 | O=C([C@@H](CCCCN)NC[C@@H](CCCCN)N)N1[C@@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(O)=O)CC(C)C)=O)[C@H](C)CC)=O)CC(C=C2)=CC=C2O)=O)CCC1 |
| EOS-AX6434 | PL 017 | 83397-56-2 | C29H37N5O5 | 535.64 | O=C([C@H]1N(C([C@H](CC(C=C2)=CC=C2O)N)=O)CCC1)N(C)[C@@H](CC3=CC=CC=C3)C(N4[C@@H](C(N)=O)CCC4)=O |
| EOS-AX6435 | BWX 46 | 172997-92-1 | C116H186N36O28S2 | 2597.09 | CCC[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC1=CC=C(O)C=C1)([H])[C@@](CC)([H])C)([H])CC(O)=N)([H])CC(C)C)([H])CSSC[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC2=CC=C(O)C |
| EOS-AX6436 | 187-1, N-WASP inhibitor | 380488-27-7 | C96H122N18O16 | 1784.13 | |
| EOS-AX6437 | K 41498 | 434938-41-7 | C162H276N48O46 | 3632.26 | |
| EOS-AX6438 | Antisauvagine-30 | 220673-95-0 | C161H273N47O47S | 3651.24 | |
| EOS-AX6439 | PHM 27 (human) | 118025-43-7 | C135H214N34O40S | 2985.44 | |
| EOS-AX6440 | GIP (human) | 100040-31-1 | C226H338N60O66S | 4983.58 | |
| EOS-AX6441 | Galnon | 475115-35-6 | C40H46N4O6 | 678.83 | O=C([C@H](CC1CCCCC1)NC(OCC2C3=CC=CC=C3C4=CC=CC=C24)=O)N[C@H](C(NC5=CC=C(C(C)=C6)C(OC6=O)=C5)=O)CCCCN |
| EOS-AX6442 | NTR 368 | 197230-90-3 | C69H124N22O19 | 1565.87 | |
| EOS-AX6443 | CALP1 | 145224-99-3 | C40H75N9O10 | 842.09 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])C(C)C)([H])C)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCCCN)([H])C(C)C)([H])CC(C)C)([H])C(C)C)([H])[C@@](O)([H])C)([H])C |
| EOS-AX6444 | Oxyntomodulin | 62340-29-8 | C192H295N59O60S | 4421.86 | |
| EOS-AX6445 | Salvinorin A | 83729-01-5 | C23H28O8 | 432.47 | O=C1[C@H]2[C@@]([C@H](C(OC)=O)C[C@@H]1OC(C)=O)(C)CC[C@@H]3[C@]2(C)C[C@@H](C4=COC=C4)OC3=O |
| EOS-AX6446 | Xenin 8 | 117442-28-1 | C51H79N15O9 | 1046.28 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@](/N=C(O)/[C@]2([H])CCCN2C([C@](N)([H])CC3=CN=CN3)=O)([H])CCCCN)([H])CCCNC(N)=N)=O)([H])CC4=CNC5=CC=CC=C45)([H])/C(O)=N/[C@@](C(O)=O)([H])CC(C)C)([H])C |
| EOS-AX6447 | [Ala11,D-Leu15]-Orexin B | 532932-99-3 | C120H206N44O35S | 2857.28 | |
| EOS-AX6448 | ZD 2079 | 178600-17-4 | C18H21NO4.HCl | 351.83 | O[C@H](C1=CC=CC=C1)CNCCOC2=CC=C(CC(O)=O)C=C2.Cl |
| EOS-AX6449 | MRS 2365 | 436847-09-5 | C13H16N5O9P2SNa3 | 549.28 | CSC1=NC(N)=C(N=CN2[C@]([C@@](O)([H])[C@]3([H])O)([H])[C@@]4([H])C[C@]43COP([O-])(OP([O-])([O-])=O)=O)C2=N1.[Na+].[Na+].[Na+] |
| EOS-AX6450 | MRS 2279 | 367909-40-8 | C13H18ClN5O8P2.2NH3 | 503.78 | CNC1=C(N=CN2[C@@]3([H])C[C@@](OP(O)(O)=O)([H])[C@]4(COP(O)(O)=O)C[C@]34[H])C2=NC(Cl)=N1.N.N |
| EOS-AX6451 | MRS 2500 tetraammonium salt | 779323-43-2 | C13H18N5O8P2I.4NH3 | 629.29 | CNC1=C(N=CN2[C@@]3([H])C[C@@](OP(O)(O)=O)([H])[C@]4(COP(O)(O)=O)C[C@]34[H])C2=NC(I)=N1.N.N.N.N |
| EOS-AX6452 | BVD 10 | 262418-00-8 | C58H92N16O13 | 1221.46 | |
| EOS-AX6453 | PDZ1 Domain inhibitor peptide | 1315378-73-4 | C38H61N9O11 | 819.95 | |
| EOS-AX6454 | Urotensin II-related peptide | 342878-90-4 | C49H64N10O10S2 | 1017.23 | CC([C@@](/N=C(O)/[C@]1([H])CSSC[C@@](/N=C(O)/[C@](N)([H])C)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CCCCN)([H])CC3=CNC4=CC=CC=C34)([H])CC5=CC=CC=C5)([H])C(O)=O)C |
| EOS-AX6455 | des-His1-[Glu9]-Glucagon (1-29) amide | 110084-95-2 | C148H221N41O47S | 3358.68 | |
| EOS-AX6456 | Rac1 Inhibitor W56 | 1095179-01-3 | C74H117N19O23S | 1671.93 | |
| EOS-AX6457 | Rac1 Inhibitor F56, control peptide | 1315378-77-8 | C72H116N18O23S | 1632.89 | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NCC(=O)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCSC)N |
| EOS-AX6458 | MNI-caged-NMDA | 1227675-52-6 | C14H17N3O6 | 323.3 | O=C(C[C@H](C(O)=O)NC)N(C1=C(C=C2)[N+]([O-])=O)CCC1=C2OC |
| EOS-AX6459 | TCS 183 | C58H96N20O20S | 1425.58 | ||
| EOS-AX6460 | L803-mts | 1043881-55-5 | C66H110N15O20P | 1464.64 | CCCCCCCCCCCCCC(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C)C(=O)N3CCCC3C(=O)N4CCCC4C(=O)NC(CCC(=O)N)C(=O)NC(COP(=O)(O)O)C(=O)N5CCCC5C(=O)N |
| EOS-AX6461 | GIP (1-39) | 725474-97-5 | C210H316N56O61S | 4633.21 | |
| EOS-AX6462 | GLP-2 (human) | 223460-79-5 | C165H254N44O55S | 3766.14 |
EOS Med Chem, Medicinal Chemical is Big is China TOP 100 CRO comapny, mainly in Med-chemicals, Custom synthesis. We have GMP, ISO plant plant serving you.
搜索此博客
2017年8月2日星期三
2017.8.3 list 12
订阅:
评论 (Atom)